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European healthcare – the good, the bad and what 
needs to be done? 
Ten years of open assessment have taught Health Consumer Powerhouse that there are 
surprisingly stable patterns of national healthcare systems of Europe. Some are quite 
positive: overall, the performance of almost every country improves year by year, offering 
more than 500 million people stronger patient influence, better access, reduced risk of 
medical failures, improved treatment outcomes and, even in times of significant funding 
pressure, extended range and reach of services in the public package. The negative impact 
from austerity policies were somewhat increased waiting in some countries (largely reversed 
in 2014) and slower inclusion of new pharmaceuticals in reimbursement systems.  
Looking forward, it would be a good idea to stop the “crisis” fixation, which in many 
countries tends to be an excuse for poor performance. Another HCP conclusion is that there 
is a rather vague correlation between financial resources and high quality care; many other 
assets are essential to deliver good performance: a culture of openness and responsibility, a 
civic climate of trust and accountability, the absence of corruption, the belief that 
empowered patients and consumers can do great things etc. Among the countries ranked by 
the 2014 Euro Health Consumer Index (EHCI) offering the best healthcare value for the 
money spent, there is a surprising number of medium and low income countries.  
To understand what these qualities are, and how they interact for good results becomes 
more and more important, as European healthcare will be under pressure to meet growing 
demand and expectations without significantly increased funding for times foreseeable. The 
recent decision of the European Commission to develop mechanisms to assess member state 
health systems can be understood in this context: health and healthcare should contribute to 
the competitiveness and progress of Europe. Or bluntly put, more and better health and 
healthcare for every euro spent.  
Such methodological evaluation of member state systems should detect what works well and 
what needs to be done in each member state, and also address: 
 How come that national healthcare, contrary to large public systems such as 
education, and every successful private business, is reluctant to learn from the best 
performers among European health? “Not invented here” is still a strong, harmful 
culture. 
 What are the lessons from some health systems (crisis-struck Baltic states the best 
example) doing the right things to recover while in other countries anarchy and 
deterioration is the pattern? 
 How to implement the values, strategies and incentives that makes some countries 
radically repair “traditional” weaknesses such as waiting lists or weak patient 
positions, while other national systems never seem to gather enough focus and 
courage. 
This is about re-shaping and modernizing the biggest industry of Europe. It is absolutely 
necessary that this huge process of replacing poor, expensive performance with modern, 
value-for-money health delivery becomes a success.  
Brussels January 27, 2015 
Johan Hjertqvist 
Founder & President 
Health Consumer Powerhouse Ltd.  
The EHCI 2014 has been supported by an unrestricted grant from Medicover S.A., Belgium. Further, 
HCP’s 2014 programme has been supported by New Direction Foundation, Belgium. 
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1. Summary  
1.1 General observations 
In spite of financial crisis-induced austerity measures, such as the much publicized 
restrictions on the increase of healthcare spend, European healthcare keeps producing better 
results. Survival rates of heart disease, stroke and cancer are all increasing, even though 
there is much talk about worsening lifestyle factors such as obesity, junk food consumption 
and sedentary life. Infant mortality, perhaps the most descriptive single indicator, also keeps 
going down, and this can be observed in countries such as the Baltic states, which were 
severely affected by the financial crisis. 
What is less encouraging is that the tendency of an increasing equity gap between wealthy 
and less wealthy European countries noted in the EHCI 20131 shows with increased clarity in 
the 2014 edition. A record of 9 countries, all Western European, are scoring above 800 
points of the maximum 1000. These are followed at some little distance by three more 
affluent countries (Austria, France and Sweden) “not quite making it” for different reasons. 
After those, there is a clearly visible gap to the next group of countries, where the first CEE 
and Mediterranean countries start appearing. This stratification is clearer in the EHCI 2014 
than in any previous edition. 
 
1.2 Country performance 
The EHCI 2014 total ranking of healthcare systems shows The Netherlands again widening 
the gap to country #2 from 19 points in 2013 to 43 points in 2014, (in 2012, the margin was 
50 points), scoring 898 points out of 1000, an EHCI all time high. Beginning from 
Switzerland (855 points) down, the EHCI 2014 shows competition at the top getting much 
harder with no less than 9 countries scoring above 800 points. 
The changes in rank should not at all be dismissed as an effect of changing indicators, of 
which there are 48 in the EHCI 2014, which is the same number as in the previous year. The 
Netherlands is the only country which has consistently been among the top three in the total 
ranking of any European Index the Health Consumer Powerhouse (HCP) has published since 
2005. The Netherlands is sub-discipline winner, or joint winner, in four of the six sub-
disciplines of the EHCI 2014. The Dutch healthcare system does not seem to have any really 
weak spots, except possibly some scope for improvement regarding the waiting times 
situation, where some central European states excel. Normally, the HCP takes care to state 
that the EHCI is limited to measuring the “consumer friendliness” of healthcare systems, i.e. 
does not claim to measure which European state has the best healthcare system across the 
board. 
However, the fact that it seems very difficult to build an Index of the HCP type without 
ending up with The Netherlands on the medallists’ podium, creates a strong temptation to 
actually claim that the winner of the EHCI 2014 could indeed be said to have “the best 
healthcare system in Europe”. There should be a lot to learn from looking deeply into the 
Dutch progress! 
Switzerland has for a long time had a reputation for having an excellent healthcare system, 
and it therefore comes as no surprise that the more profound research which eliminated 
most n.a. scores results in a prominent position in the EHCI. 
Bronze medallists are Norway at 851 points; the very high per capita spend on healthcare 
services finally paying off! 
                                           
1 www.healthpowerhouse.com/files/ehci-2013/ehci-2013-report.pdf  
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Finland (4th, 846 points) has made a remarkable advance, and seems to have rectified its 
traditional waiting time problems! 
Denmark (5th, 836 points) did gain a lot from the introduction of the e-Health sub-discipline. 
Non the less, as can been seen from the longitudinal analysis in Chapter 6, Denmark has 
been on a continuous rise since it was first included in the EHCI 2006, until competition 
tightened in 2014.  
The Swedish score for technically excellent healthcare services is, as ever, dragged down by 
the seemingly never-ending story of access/waiting time problems, in spite of national efforts 
such as Vårdgaranti (National Guaranteed Access to Healthcare); in 2014, Sweden drops to 
12th place with 761 points. 
In southern Europe, Spain and Italy provide healthcare services where medical excellence 
can be found in many places. Real excellence in southern European healthcare seems to be 
a bit too much dependent on the consumers' ability to afford private healthcare as a 
supplement to public healthcare. Also, both Spain and Italy show large regional variation, 
which tends to result in a lot of Amber scores for the countries. 
Some eastern European EU member systems are doing surprisingly well, particularly the 
Czech Republic and Estonia, considering their much smaller healthcare spend in Purchasing 
Power Parity (PPP) adjusted dollars per capita. However, readjusting from politically planned 
to consumer-driven economies does take time. 
The FYR Macedonia is making the most remarkable advance in the EHCI scoring of any 
country in the history of the Index, from 27th to 16th place, largely due to more or less 
eliminating waiting lists by implementing their real time e-Booking system! 
Consumer and patient rights are improving. In a growing number of European countries 
there is healthcare legislation explicitly based on patient rights and a functional access to 
your own medical record is becoming standard. Hospital/clinic catalogues with quality 
ranking used to be confined to two – three countries for years; the 2014 number of nine 
countries hopefully is a sign that something is happening in this area. Medical travel 
supported by the new patient mobility directive can accelerate the demand for performance 
transparency. After the cross-border directive, the criteria for this indicator have been 
tightened to reflect the implementation of this directive. Not unexpectedly, in 2013 the only 
countries to score Green were The Netherlands and Luxembourg, who have been allowing 
cross-border care seeking for years. 
1.3 Some interesting countries 
1.3.1 The Netherlands!!! 
The Netherlands is the only country which has consistently been among the top three in the 
total ranking of any European Index the Health Consumer Powerhouse has published since 
2005. The 2012 NL score of 872 points was by far the highest ever seen in a HCP Index. The 
898 points in 2014 are even more impressive, as it becomes increasingly difficult to reach a 
very high score on many indicators – no country is superbly good at everything. What 
prevented The NL from breaking the 900-barrier was the Red score earned for smoking 
prevention, graded on the Tobacco Control Scale 2013. Also, the only Index in recent years 
where the NL have not been among the top three countries was the Tobacco Harm 
Prevention Index, where a rather liberal Dutch attitude was detected. 
Between the latest EHCI editions, The Netherlands have also scored 922 points in the Euro 
Diabetes Index 2014. That score would normally have been a secure Gold medal – in the 
EDI, that was seized by Sweden at 936 points on the power of having data on all indicators. 
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6 
 
Euro Health Consumer Index 2014 
The NL wins four of the six sub-disciplines of the Index, and the large victory margin seems 
essentially be due to that the Dutch healthcare system does not seem to have any really 
weak spots, except possibly some scope for improvement regarding the waiting times 
situation, where some central European countries excel.  
Normally, the HCP takes care to state that the EHCI is limited to measuring the “consumer 
friendliness” of healthcare systems, i.e. does not claim to measure which European state has 
the best healthcare system across the board. 
Counting from 2006, the HCP has produced not only the generalist Index EHCI, but also 
specialist Indexes on Diabetes, Cardiac Care, HIV, Headache and Hepatitis. The Netherlands 
are unique as the only country consistently appearing among the top 3 – 4, regardless what 
aspects of healthcare which are studied. This creates a strong temptation to actually claim 
that the landslide winner of the EHCI 2014 could indeed be said to have “the best healthcare 
system in Europe”. 
1.3.1.1 So what are the Dutch doing right? 
It has to be emphasized that the following discussion does contain a substantial amount of 
speculation outside of what can actually be derived from the EHCI scores: 
The NL is characterized by a multitude of health insurance providers acting in competition, 
and being separate from caregivers/hospitals. Also, the NL probably has the best and most 
structured arrangement for patient organisation participation in healthcare decision and 
policymaking in Europe. 
Also, the Dutch healthcare system has addressed one of its few traditional weak spots – 
Accessibility – by setting up 160 primary care centres which have open surgeries 24 hours a 
day, 7 days a week. Given the small size of the country, this should put an open clinic within 
easy reach for anybody. 
Here comes the speculation: one important net effect of the NL healthcare system structure 
would be that healthcare operative decisions are taken, to an unusually high degree, by 
medical professionals with patient co-participation. Financing agencies and healthcare 
amateurs such as politicians and bureaucrats seem farther removed from operative 
healthcare decisions in the NL than in almost any other European country. This could in itself 
be a major reason behind the NL landslide victory in the EHCI 2014. 
1.3.1.2 So what, if anything, are the Dutch doing wrong? 
The NL scores well or very well in all sub-disciplines, except possibly Accessibility and 
Prevention, where the score is more mediocre – on the other hand, so are those of most 
other countries.  
The “traditional” Dutch problem of mediocre scores for Waiting times has to a great extent 
been rectified by 2014. As was observed by Siciliani & Hurst of the OECD in 2003/2004, and 
in the EHCI 2005 – 2014, waiting lists for specialist treatment, paradoxically, exist mainly in 
countries having “GP gatekeeping” (the requirement of a referral from a primary care doctor 
to see a specialist). 
GP gatekeeping, a “cornerstone of the Dutch healthcare system” (said to the HCP by a 
former Dutch Minister of Health) is widely believed to save costs, as well as providing a 
continuum of care, which is certainly beneficial to the patient. As can be seen from the 
references given in Section 8.10.2 on indicator 2.2, there is no evidence to support the cost-
reducing hypothesis. Also, as can be seen in Section 5.1, the NL has risen in healthcare 
spend to actually having the highest per capita spend in Europe (outside of what the HCP 
internally calls “the three rich bastards”; Norway, Switzerland and Luxembourg, who have a 
GDP per capita in a class of their own). This was observed already in the EHCI 2009, and the 
situation remains the same. 
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1.3.1.3 But Dutch healthcare is terribly expensive, is it not? 
This has been extensively treated in the EHCI 2013 report2. 
It seems that actual modes of operating the healthcare system in The Netherlands could 
explain the high per capita healthcare spend, i.e. not the multi-payor model. If the country 
can afford this, fine; but also for Outcomes and patient quality of life reasons, a programme 
to reduce the share of in-patient care would be beneficial for the Dutch healthcare budget! 
 
1.3.2 Switzerland 
Silver medallists, 855 points (up from 851). 
Switzerland has enjoyed a solid reputation for excellence in healthcare for a long time. 
Therefore it is not surprising that when the n.a.’s of previous EHCI editions have mainly 
been eliminated, Switzerland scores high. Considering the very respectable costs ploughed 
into the Swiss healthcare system, it should! Along with Belgium, the only country to score All 
Green on Accessibility. 
In 2014, Switzerland is leading a “hornets’ nest” of Western European Countries scoring 
above 800 points! 
1.3.3 Norway 
3rd place, 851 points. Norwegian wealth and very high per capita spend on healthcare seem 
to be paying off – Norway has been slowly but steadily rising in the EHCI ranking over the 
years. Traditionally, Norwegian patients complained about waiting times – this has subsided 
significantly. Good outcomes, but sometimes surprisingly restrictive on innovative 
pharmaceuticals on grounds, which can hardly be financial. 
 
1.3.4 Finland 
4th, 846 points. As the EHCI ranking indicates, Finland has established itself among the 
European champions, with top outcomes at a fairly low cost. In fact, Finland is a leader in 
value-for-money healthcare. 
Compared with Sweden, Denmark and other Nordic countries, Finnish healthcare is 
somewhat old-style in the sense that national authorities have not paid too much attention 
to user-friendliness. This means that some waiting times are still long, provision of “comfort 
care” such as cataract surgery and dental care is limited and that out of pocket-payment, 
also for prescription drugs, is significantly higher than for Nordic neighbours. 
This probably means that the public payors and politicians are less sensitive to “care 
consumerism” than in other affluent countries. Even if the outcomes are excellent, the 
rationing of expensive care such as kidney transplants probably takes its toll. Finnish “sisu” is 
no remedy for severe illness. 
 
1.3.5 Denmark 
Denmark was catapulted into 2nd place by the introduction of the e-Health sub-discipline in 
the EHCI 2008. Denmark has been on a continuous rise since it was first included in the 
EHCI 2006. Interestingly, when the EHCI 2012 was reverted to the EHCI 2007 structure, 
                                           
2 www.healthpowerhouse.com/files/ehci-2013/ehci-2013-report.pdf  
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Denmark survived this with flying colours and retained the silver medal with 822 points! 
However, in 2013, the introduction of the Prevention sub-discipline did hot help Denmark, 
which lost 20 points on this sub-discipline relative to aggressive competitors, but still scores 
an impressive 836 points and a 5th place in the EHCI 2014. A not-very-scientific 
interpretation of the loss on Prevention is provided by the classic Danish reply when 
confronted with the fact that male life expectancy is 5 years less in Denmark than across the 
water in Sweden: “We have more fun while it lasts!” 
Denmark has also made dramatic advancement in the reduction of heart disease mortality in 
recent years.  
Denmark is one of only three countries scoring on “Free choice of caregiver in the EU” after 
the criteria were tightened to match the EU directive, and also on having a hospital registry 
on the Internet showing which hospitals have the best medical results.  
1.3.6 Belgium 
Perhaps the most generous healthcare system in Europe3 seems to have got its quality and 
data reporting acts together, and ranks 6th in the EHCI 2013 (797 points). A slightly negative 
surprise is that Belgium still, as in 2012, has the worst number for acute heart infarct 
survival in hospital in the OECD Health Data. 
1.3.7 Iceland 
Due to its location in the North Atlantic, Iceland has been forced to build a system of 
healthcare services, which has the capability (not dimensions!) of a system serving a couple 
of million people, which is serving only 300 000 Icelanders. The Icelandic 7th place, with 818 
points, does not come as a surprise to the HCP research team. 
Iceland is handicapped in the Index by being outside of the EU. In 2014, drug sales data 
available to the EHCI project have been supplied by the Icelandic pharmacy benefits system. 
It also seems that all speculation about the financial crisis affecting Icelandic healthcare has 
been exaggerated. Basically, Iceland is a very wealthy country, which is also proved by the 
speedy recovery from the crisis. 
Lacking its own specialist qualification training for doctors, Iceland does probably benefit 
from a system, which resembles the medieval rules for carpenters and masons: for a number 
of years after qualification, these craftsmen were forbidden to settle down, and forced to 
spend a number of years wandering around working for different builders. Naturally, they did 
learn a lot of different skills along the way. Young Icelandic doctors generally spend 8 – 10 
years after graduation working in another country, and then frequently come back (and they 
do not need to marry a master builder’s widow to set up shop!). Not only do they learn a lot 
– they also get good contacts useful for complicated cases: the Icelandic doctor faced with a 
case not possible to handle in Iceland, typically picks up the phone and calls his/her ex-boss, 
or a skilled colleague, at a well-respected hospital abroad and asks: Could you take this 
patient?, and frequently gets the reply: “Put her on a plane! 
1.3.8 Luxembourg 
Luxembourg (8th, 814 points), being the wealthiest country in the EU, could afford to build 
its own comprehensive healthcare system. Unlike Iceland, Luxembourg has been able to 
capitalize on its central location in Europe. With a level of common sense which is unusual in 
the in-sourcing-prone public sector, Luxembourg has not done this, and has for a long time 
allowed its citizens to seek care in neighbouring countries. It seems that they do seek care in 
good hospitals. 
                                           
3 Some would say over-generous: a personal friend of the HCP team, living in Brussels, was “kidnapped and held” 
in hospital for 6 days(!) after suffering a vague chest pain one morning at work. 
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1.3.9 Germany  
Germany (9th, 812 points) took a sharp dive in the EHCI 2012, sliding in the ranking from 6th 
(2009) to 14th. As was hypothesised in the EHCI 2012 report, when patient organisations 
were surprisingly negative, this could have been an artefact created by “German propensity 
for grumbling”, i.e. that the actual deterioration of the traditionally excellent accessibility to 
health care was less severe than what the public thought, and the negative responses were 
an artefact of shock at “everything not being free anymore”. 
The 2014 survey results seem to confirm this theory, and it would appear that German 
patients have discovered that “things are not so bad after all”, with Mrs. Merkel being Queen 
of Europe. 
Germany has traditionally had what could be described as the most restriction-free and 
consumer-oriented healthcare system in Europe, with patients allowed to seek almost any 
type of care they wish whenever they want it (“stronger on quantity than on quality”). The 
traditional weakness of the German healthcare system: a large number of rather small 
general hospitals, not specializing, resulting in mediocre scores on treatment quality, seems 
to be improving. 
In the feedback round from national healthcare bodies, the response from the German 
Bundesministerium für Gesundheit (BMG) contained an interesting reference to a study of 
waiting times in German primary care. It is almost irrelevant what the actual numbers were 
in that study; the unit of time used to measure and analyse primary care accessibility was 
not months, weeks or days, but minutes! 
1.3.10 Austria 
Austria (10th, 780 points) suffered a drop in rank in 2012, and made a slight rebound in 2013 
(cf. Germany). 
In 2014, Austria makes up a distinct trio with France and Sweden, >30 points behind the top 
countries but >40 points ahead of the rest of the field. The introduction of the Abortion 
indicator did not help: Austria does not have the ban on abortion found in Poland and three 
more countries, but abortion is not carried out in the public healthcare system. Whether 
Austria should deserve a Red or an n.a. score on this indicator could be a matter of 
discussion – there are no official abortion statistics. 
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1.3.11 United Kingdom – England vs. Scotland 
England 14th place, 718 points and Scotland 16th, 710 points. For several 
years, the HCP has been urged to separate England and Scotland in the EHCI 
on the grounds that “Scotland has its own National Health Service”. In the 
EHCI 2014, this has been done for the second time. Another reason to 
separate out Scotland is that the Scottish healthcare spend per capita is ~10 
% higher than the English – would that make a difference? 
The Scottish NHS deserves recognition for providing excellent Internet access 
to healthcare data (www.isdscotland.org/), going to such lengths as producing 
a special version of the WHO Health for All database (2012) with Scotland as a 
separate country. The only problem with Scottish data is that in true British 
tradition, parameters are not necessarily measured in a way which is 
compatible with WHO or other measurements. One example is Alcohol intake, 
where the common measure is “litres of pure alcohol per year”. The Scottish 
data are “units of alcohol per day/week”. Fortunately, on this and other 
parameters, the same method of measuring can be found for other parts of 
the UK. As the scoring in the EHCI is a relative measurement, the Scottish 
scores on some indicators have been obtained by comparing with England. 
One such is Depression, where Scotland does not appear in the main source 
used (a Eurobarometer survey). The Scottish Red score stems from a BBC 
news item stating that 15 % of Scots seek medical attention for depression 
every year4, which is almost twice the number for England. 
As can be seem in the excerpt from the EHCI matrix (right), there are 11 
indicators out of 49, where Scotland and England score differently. As is 
shown by the graphs in Section 8.10, the actual difference is modest in most 
of these cases. Still, the difference in total score: 710 for Scotland and 718 for 
England, is small! 
One reason for the very small Scottish shortcoming is the “Dr. Foster” 
indicator; the UK was European pioneers at publishing Outcomes data for 
individual hospitals. Today, NHS England has developed that (“NHS Choices”) 
and also toward publishing results for individual doctors, while NHS Scotland is 
not providing hospital level information to the public! 
An interesting corner of the matrix is Outcomes for Heart Infarct and Stroke: if 
the EHCI were to use public health indicators, Scotland would score markedly 
worse than England. It seems that Scottish healthcare has geared up to this, 
and knowing that heart disease is a big problem in Scotland have put an effort 
into providing good care for CVD conditions. An interesting parallel case would 
be Poland, which has a CVD death rate on par with Germany or Sweden; 
approximately half of that of neighbours Czech Republic or the Baltic states. 
As one panel expert said about Polish good results: “They certainly have a lot 
of cardiologists!” 
The Heart indicator has changed since 2013; data on case fatality was notoriously shaky. 
The 2014 indicator is “the steepness of the downward trend of ischaemic heart disease 
mortality”. This made it possible to construct a stroke indicator on the same principle. 
England and Scotland receive the same score on both indicators. In 2013, Scotland 
outscored England on the Heart indicator, which explains why England pulls ahead in the 
2014 Index. 
                                           
4 http://news.bbc.co.uk/2/hi/uk_news/scotland/1466882.stm 
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The EHCI patient organisation survey confirms the claims from the English NHS that the very 
large resources invested in reducing waiting list problems in British healthcare have paid off, 
even though the U.K. is still definitely a part of European “waiting list territory” (see also 
Section 6.6!). Unfortunately, in 2014 the English Waiting Time scores are worsening slightly, 
which is confirmed by English press reports on healthcare accessibility. The efforts to clean 
up hospitals to reduce resistant hospital infections have also paid off: UK England scores 
Amber on this indicator. Having reduced the share of hospital infections being resistant from 
around 45% down to ~15% is a unique performance for a European country. Unfortunately, 
England does score a straight Amber also on all the other Outcomes indicators, except the 
trend line for cardiac deaths. 
There is really no reason to expect to find significant differences between England and 
Scotland merely because they have separate healthcare administrations. The basic 
organisational cultures are still very similar, entrenched in GP referral systems, which not 
unexpectedly are associated with waiting times for specialist services. It should be noted that 
there is very little evidence that having separate sets of bureaucrats does influence anything. 
Expecting minimal differences would therefore be the natural thing. 
If connected with things in real life at all, the 10 % higher per capita healthcare spend in 
Scotland could at least partially be motivated by public health factors such as heart disease, 
alcohol consumption and depression being bigger problems in Scotland than in England. A 
10% cost difference is a major problem in private industry. In the public sector, including 
healthcare, it is not uncommon to find cost differences >30%, which are not reflected in 
significant differences in performance. 
1.3.12 Ireland 
22nd place (not counting Scotland), down from 14th in 2013. 
Ireland has detailed official statistics on waiting times all over healthcare, and that data was 
been allowed to prevail up until EHCI 2013. However, for several EHCI years, Irish patient 
organisations have been radically more pessimistic in their responses to the survey 
conducted as part of EHCI research. It is well known that customers/patients have long 
memories for less good things. As the same pessimistic results reoccurred in 2014 – Ireland 
and Sweden had the worst patient organisation feedback on Accessibility among the 37 
countries – doubts must be raised on the validity of official statistics. 
As a matter of principle, in the EHCI 2014 it was decided to use the patient organisation 
feedback to score Ireland on Accessibility. This accounts for the drop from rank 14 to 22. 
The fact that Ireland has the highest % of population (> 40 %; down from 52 % two years 
ago5) purchasing duplicate healthcare insurance also presents a problem: should that be 
regarded as an extreme case of dissatisfaction with the public system, or simply as a 
technical solution for progressive taxation? 
Ireland no longer has a total ban on abortion. The requirement that a woman wishing an 
abortion becomes subject to judgement on if the pregnancy should be regarded as a serious 
health hazard, including suicide risk, is a very minor step indeed towards abortion as a 
women’s right. 
1.3.13 Sweden 
Sweden tumbled in the EHCI 2013 from 6th place to 11th at 756 points, which was only 6 
points down from the 2012 value of 762 points. In the EHCI 2014, Sweden is down another 
position to #12, with 761 points. The reason for the loss of positions thus cannot be said to 
                                           
5 OECD Health at a Glance, 2012. 
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be that healthcare services in Sweden have become worse, but that other countries have 
improved more. In 2014, with nine countries scoring above 800, Sweden, France and Austria 
make up a distinct trio, scoring >30 points less than the top nine, but >40 points ahead of 
the pack. 
Sweden scores surprisingly well in the sub-discipline Prevention, considering that the 
country’s healthcare system has a long tradition of steering patients away from taking up 
time for their doctor unless really sick. 
Sweden loses vital points as it no longer scores All Green on Outcomes after the introduction 
of the indicator Abortion rates. Sweden enjoys the companionship only of a number of CEE 
countries having more than 30 abortions per 100 live births, which in turn is probably a left-
over from before 1990. In Russia, abortion is still used as a common contraceptive, with 95 
abortions per 100 births (and that is down from 160 in the mid-1990’s). It should be added 
that EHCI takes a critical view on the four countries executing a legal ban on abortion. 
At the same time, the notoriously poor Swedish accessibility situation seems very difficult to 
rectify, in spite of state government efforts to stimulate the decentralized county-operated 
healthcare system to shorten waiting lists by throwing money at the problem (“Queue-
billions”). The HCP survey to patient organizations confirms the picture obtained from the 
official source www.vantetider.se, that the targets for maximum waiting times, which on a 
European scale are very modest, are not really met. The target for maximum wait in Sweden 
to see your primary care doctor (no more than 7 days) is underachieved only by Portugal, 
where the corresponding figure is < 15 days. In the HCP survey, Swedish and Irish patients 
paint the most negative pictures of accessibility of any nation in Europe. Particularly cancer 
care waits, not least in the capital Stockholm, seem inhumane! 
Another way of expressing the vital question: Why can Albania operate its healthcare 
services with practically zero waiting times, and Sweden cannot? 
1.3.14 Portugal 
Continues its very impressive climb: In 2013, 16th place on 671 points (up from 25th place in 
2012). In 2014, Portugal advances to 13th place with 722 points, just ahead of the UK! This 
is all the more remarkable, as Portugal is one of the countries most notably affected by the 
euro crisis! 
 
1.3.15 The Czech Republic  
The Czech Republic has always been the star performer among CEE countries, and in 2014 
retains its 15th place, leading the group of CEE countries and squeezing in between England 
and Scotland. 
1.4 The Balkans 
As there now are no less than nine Balkan countries in the EHCI – four EU-members and five 
countries with various ambitions of becoming members – a deeper look into this region can 
be of interest: 
The term Balkans comprises6 the following countries included in the EHCI 2014: 
 Albania 
 Bosnia and Herzegovina 
 Bulgaria 
                                           
6 Bideleux, Robert; Taylor, Richard (1996). European integration and disintegration: east and west. p. 249. 
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 Croatia 
 Greece 
 FYR Macedonia 
 Montenegro 
 Romania 
 Serbia 
Although Slovenia does not unequivocally count as a geographic part of the Balkans, it will 
be discussed under this section because of its history as part of Yugoslavia 1918 – 1991. 
Except Greece, Slovenia and Croatia, the Balkans contain the poorest states included in the 
EHCI, as is shown in the Graph below. Unfortunately, this coincides with a high level of 
corruption as measured by Transparency International7. As can be seen from the Graph, 
there is a fairly close correlation between poverty and high levels of corruption, with Greece 
and Italy deviating in showing a worse corruption Index score than would be expected from 
their levels of wealth. The question whether poverty leads to corruption or corruption 
causes/maintains poverty is beyond the scope of the EHCI study. 
 
Figure 1.2 Corruption scores and GDP/capita. The Balkans are marked with dark blue GDP (broad) 
bars. On the corruption scale, a score of 100 denotes a corruption-free country; the lower the score, 
the more severe the corruption. Apart from Greece and Italy, there is a quite close correlation (R = 
81%) between poverty and corruption. 
                                           
7 http://www.transparency.org/cpi2014/results  
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Figure 1.2-2 EHCI 2014 total scores with Balkan states in yellow.  
1.4.1 Former Yugoslav Republic Of Macedonia (FYROM) 
FYROM remained at peace through the Yugoslav wars of the early 1990s. However, it was 
seriously destabilised by the Kosovo War in 1999, when an estimated 360,000 ethnic 
Albanian refugees from Kosovo took refuge in the country, most leaving fairly soon after. 
FYROM is the absolute “Rocket of the Year”, ranking 16th in the EHCI 2014 with a score of 
700 points, up from 555 points and 27th place in 2013. 
This also makes the country the “EHCI Rocket of all Time”; no country ever gained 11 
positions in the ranking in only one year! 
The country has made a remarkable breakthrough in electronic booking of appointments – 
since July 2013, any GP can call up the booking situation of any specialist or heavy 
diagnostic equipment in the country in Real Time with the patient sitting in the room, and 
book anywhere in the country with a few mouse clicks. This has essentially eliminated 
waiting times, provided that the patient is willing to travel a short distance (the entire 
country measures approximately 200 km by 130, with the capital Skopje located fairly 
centrally). It seems that patients have caught on, with FYROM receiving top scores for 
accessibility.  
Much of this can probably be attributed to firm leadership, with the Minister of Health 
declaring “I want that system up and running on July 1, 2013; basta! 
The FYROM referral/booking system is well worth a study trip from other countries! The 
message to all other European ministers and other persons in charge of healthcare systems: 
“Go and do likewise.”8 This advice does not exclude that e-health implementation most often 
                                           
8 Luke 10:37 
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may need some time to settle and that down-sides can occur over time, before patients get 
used to their newborn power and choice. 
The area, where FYROM still has a way to go is on actual medical treatment results. There is 
no quick fix for this; even with very determined leadership, it will probably be a matter of ~5 
years to produce significant improvement. 
1.4.2 Albania 
30th place, 545 points. Albania is included in the EHCI at the request of the Albanian Ministry 
of Health. Albania, as can be seen in Section 5.1, does have very limited healthcare 
resources. The country avoids ending up last chiefly due to a very strong performance on 
Access, where patient organizations also in 2014 confirmed the official ministry version that 
waiting times essentially do not exist.  
The ministry explanation for this was that “Albanians are a hardy lot, who only go to the 
doctor when carried there”, i.e. underutilization of the healthcare system. This is an 
oversimplification; Albanians visit their primary care doctor more than twice as often as 
Swedes (3.9 visits per year vs. 1.7)! 
Albania shares one problem with all the Balkan states, with some exception for Slovenia: it is 
difficult to evaluate which healthcare services are accessible without under-the-table 
payment. 
1.4.3 Bosnia and Herzegovina (“B&H”) 
B&H is a country in great difficulties. As Republica Srpska, with its unofficial capital of Banja 
Luka, has control over almost half the country, it is hard for the “federal” government in 
Sarajevo to influence very much at all. B&H is occupying last place in the EHCI 2014, largely 
due to a massive number of n.a. scores. The survey deployed as part of the EHCI research 
failed to produce a single response from the country. However, the general state of things in 
B&H makes it probable that the rank would be the same, had data been available. 
Brain drain is also a severe problem for B&H, as for many other Balkan countries: an obvious 
choice for young doctors when seeking employment is to emigrate to prosperous parts of the 
EU, with Germany being perceived as the main attraction. 
1.4.4 Serbia 
33rd place, 473 points. 
After Serbia’s first inclusion in the EHCI in 2012 (finishing last), there were some very strong 
reactions from the Ministry of Health in Belgrade, claiming that the scores were unfair. 
Interestingly, there also were reactions from organisations of medical professionals in Serbia 
claiming that the Serbian scores were inflated, and that the EHCI did not take corruption in 
healthcare systems seriously enough. The only directly corruption-related indicator is Under-
the-table payments to doctors, where Serbia does score Red. Unfortunately, Serbia finished 
last also in 2013. 
After several years, there was a change of government in Serbia after the April 2014 
election. The new government seems to be making a sincere effort at reforming the 
healthcare system. A palpable circumstance is the appointment of the Chairperson of 
“Doctors Against Corruption” as Special Adviser to the Ministry of Health. 
In 2014, Serbia has behind it in the EHCI not only Bosnia & Herzegovina and Montenegro, 
but has also overtaken Romania. However, it still has a long way to go to catch up with the 
more developed Balkan states. 
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1.4.5 Montenegro 
34th place, 463 points. Battling with Serbia and Romania to avoid 35th (second last) place in 
the EHCI. Used to remain in union with Serbia until 2006. The healthcare situation is most 
likely very similar to that of Serbia. One circumstance favouring Montenegro is a massive 
influx of Russian capital, which at the time of writing this report might be endangered by 
sanctions against Russian capitalists after the seizure of Crimea. 
Montenegrin healthcare is showing promise: the score on Medical Outcomes is good, 
compared with that of neighbouring countries. The country has only 650 000 inhabitants, 
making it possible for reforms to take effect rapidly. 
 
1.4.6 Greece 
In 28th place (not counting Scotland), down from 22nd in 2012, 25th in 2013. 
Greece was reporting a dramatic decline in healthcare spend per capita: down 28 % 
between 2009 and 2011, but a 1% increase in 2012! This is a totally unique number for 
Europe; also in countries which are recognized as having been hit by the financial crisis, such 
as Portugal, Ireland, Spain, Italy, Estonia, Latvia, Lithuania etc, no other country has 
reported a more severe decrease in healthcare spend than a temporary setback in the order 
of < 10 % (see Appendix 2). There is probably a certain risk that the 28% decrease is as 
accurate as the budget numbers, which got Greece into the Euro. 
Greece has markedly changed its traditional habit as eager and early adopter of novel 
pharmaceuticals to become much more restrictive. However, the graph below shows that as 
late as 2012, Greece still had the 3rd highest per capita consumption of pharmaceuticals in 
Europe, counted in monetary value! Part of the explanation for this is unwillingness to accept 
generic drugs. It would seem that pharmacists (and doctors?) are not keen on 
communicating to patients that generics are equal to the branded drugs. 
What has changed in Greece is the readiness to adopt new drugs. As Indicator 6.5 (new 
arthritis medication) shows, Greece has in some cases radically changed its previous 
generous attitude to the introduction of novel, expensive pharmaceuticals. 
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Greece leads Europe by a wide margin in the number of doctors per capita (below), and also 
has the highest number of pharmacists per capita. Still the picture of Greek healthcare, 
painted by the patient organisation responses, does not at all indicate any sort of healthy 
competition to provide superior healthcare services. 
 
Figure 1.1.12 Physicians per 100 000 population (broad bars) and Number of doctor appointments per 
capita (yellow narrow bars). 
It would seem almost supernatural that Greece can keep having the large number of doctors 
and pharmacists (a report from 2013 still gives >6 doctors per 1000 population), unless 
these have taken very substantial reduction of income. 
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It deserves to be mentioned that the indicators on Outcomes (treatment results) do not 
show a worsening of results for Greece. 
1.4.7 Romania 
35th place, 453 points. 
Romania does have severe problems with the management of its entire public sector. In 
healthcare, discrimination of minority groups such as romani (3½ - 4% of the population) 
shows as poor Outcomes ratios. 
Also, Albania, Romania and Bulgaria are suffering from an antiquated healthcare structure, 
with a high and costly ratio of in-patient care over out-patient care (see Figure below). 
 
Figure 1.2.7 The higher the share of in-patient care, the more antiquated the healthcare provision 
structure. If Dutch, Swiss and Norwegians prefer long hospital admissions, they can afford it; Bulgaria, 
Romania and Albania cannot! They should receive professional support to restructure their healthcare 
services! 
1.4.8 Bulgaria 
29th place, 547 points. 
Bulgaria made a remarkable advance between 2012 and 2013 by the power of patient 
organisations in 2013 giving much more positive responses on survey questions on the EHCI 
sub-discipline Accessibility. Such an improvement is very difficult to achieve if it is not the 
result of a system reform such as the FYROM booking/referral system. The HCP team is still 
a shade unconvinced that the good accessibility numbers in 2013 – 14 are accurate. 
1.4.9 Croatia 
23rd place, 640 points. Croatia (and even more Slovenia) were the remarkable success 
stories among the ex-Yugoslavian countries, until the Macedonian wonder in 2014. In spite 
of a GDP/capita, which is still modest by Western European standards, Croatian healthcare 
does excel also at advanced and costly procedures such a kidney transplants: the Croatian 
number of ~50 transplants per million population is among the top countries of Europe. 
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1.4.10 Slovenia 
19th place, 668 points. 
When the HCP team first visited the Slovenian Ministry of Health in 2006, the MoH 
representatives proudly stated “We are not a Balkan state – we are an Austrian province, 
which had bad luck in 1918!” 
Slovenia has a GDP/capita which is 3 – 4 times that of the other ex-Yugoslav countries 
(except Croatia at ~75% of the Slovenian GDP). This difference cannot have been created in 
just over two decades – Tito’s Yugoslavia must have had significant internal inequalities! 
Slovenia’s 19th place is a respectable performance considering the country’s recent history. 
What is more remarkable is that with a population of only 2 million, there is a possibility for a 
limited number of skilled and dedicated professionals to make a difference in certain medical 
specialities. This has been observed in hepatitis, where Slovenia ranked #2 in Europe in the 
2012 Euro Hepatitis Index9, and also in diabetes, Slovenia ranking #6 in the 2014 Euro 
Diabetes Index10. 
 
1.5 Financial crisis impact on European healthcare? 
This is one of the most frequent questions asked to HCP staff in meetings with healthcare 
decision makers. This issue has been given special attention in the work on the EHCI since 
2012. 
The EHCI 2013 introduced more indicators in the sub-disciplines Range and reach of services 
and Pharmaceuticals, plus the new sub-discipline Prevention (totally 48 indicators vs. 42 in 
2012). The more indicators introduced, the more difficult it becomes for countries to reach 
very high scores, as no country is excellent at everything. If the number of indicators were 
to be increased dramatically, countries would tend to migrate towards the “centre of 
gravity”, which is 667 points. Also, with the exception of a few indicators, the score 
distribution is strictly relative, why it is difficult to use the straight mean score to detect 
differences over time. 
However, the overall total scores seem to indicate what could be a macro effect of the 
financial crisis. In the total scores shown in Figure 4.1 below, the top end of the ranking in 
2014 shows a concentration of the wealthier countries, which is more obvious than in any 
previous edition. It would seem that these countries have been able to avoid the (rather 
modest) effects of the financial crisis, which have affected less affluent countries. 
This can be interpreted that the financial crisis has resulted in a slight but 
noticeable increase of inequity of healthcare services across Europe. 
When results are analysed at indicator level, some tendencies seem to be detectable: 
1.5.1 Outcomes quality keeps improving 
Indicators such as Cancer Survival or Infant Mortality keep showing improvement over time. 
This is true also for countries such as the Baltic states, which have undergone a financial 
“steel bath”, in every way comparable with that hit southern Europe or Ireland. As an 
example, both Latvia and Lithuania have shown remarkable improvement in Infant Mortality 
right during the period of the worst austerity measures. 
                                           
9 http://www.healthpowerhouse.com/files/euro-hepatitis-index-2012/Report-Hepl-HCP-121104-2-w-Cover.pdf  
10 http://www.healthpowerhouse.com/files/EDI-2014/EDI-2014-report.pdf  
 ________________________________________________________________ 
20 
 
Euro Health Consumer Index 2014 
This is probably a positive effect of doctors being notoriously difficult to manage – signals 
from managers and/or politicians are frequently not listened to very attentively. This would 
be particularly true about providing shoddy medical quality as this would expose doctors to 
peer criticism, which in most cases is a stronger influencing factor than management or 
budget signals. 
1.5.2 Delays and/or restrictiveness on the introduction of novel pharmaceuticals 
As is shown by Indicators 6.3 – 6.5 (section 8.10.6), saving on the introduction/deployment 
of drugs, particularly novel, patented (expensive) drugs, seems to be a very popular tactic 
for containing healthcare costs in many countries. This has been observed also in previous 
HCP Indices11. 
This is particularly obvious for Greece – a country, which traditionally has been a quick and 
ready adopter of novel drugs. The Greek public bill for prescription drugs was 8 billion euro 
as late as 2010, for 11 million people. As a comparison, the Swedish corresponding number 
was 4 billion euros for 9½ million people – and drug prices have traditionally been lower in 
Greece. That Greek readiness to introduce new drugs has dropped dramatically, along with 
the introduction of generic substitution. 
Still, the Greek drug consumption by monetary value was the third highest in Europe as late 
as 2012! 
1.6 BBB; Bismarck Beats Beveridge – now a permanent feature 
The Netherlands example seems to be driving home the big, final nail in the coffin of 
Beveridge healthcare systems, and the lesson is clear: Remove politicians and other 
amateurs from operative decision-making in what might well be the most complex industry 
on the face of the Earth: Healthcare! Beveridge systems seem to be operational with good 
results only in small population countries such as Iceland, Denmark and Norway. 
1.6.1 So what are the characteristics of the two system types? 
All public healthcare systems share one problem: Which technical solution should be used to 
funnel typically 8 – 11 % of national income into healthcare services? 
Bismarck healthcare systems: Systems based on social insurance, where there is a 
multitude of insurance organisations, Krankenkassen etc, who are organisationally 
independent of healthcare providers. 
Beveridge systems: Systems where financing and provision are handled within one 
organisational system, i.e. financing bodies and providers are wholly or partially within one 
organisation, such as the NHS of the UK, counties of Nordic states etc. 
For more than half a century, particularly since the formation of the British NHS, the largest 
Beveridge-type system in Europe, there has been intense debating over the relative merits of 
the two types of system. 
Already in the EHCI 2005, the first 12-state pilot attempt, it was observed that “In general, 
countries which have a long tradition of plurality in healthcare financing and provision, i.e. 
with a consumer choice between different insurance providers, who in turn do not 
discriminate between providers who are private for-profit, non-profit or public, show 
common features not only in the waiting list situation …” 
                                           
11 The Euro Hepatitis Index 2012, http://www.healthpowerhouse.com/files/euro-hepatitis-index-2012/Report-
Hepl-HCP-121104-2-w-Cover.pdf 
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Looking at the results of the EHCI 2006 – 2014, it is very hard to avoid noticing that the top  
consists of dedicated Bismarck countries, with the small-population and therefore more 
easily managed Beveridge systems of the Nordic countries squeezing in. Large Beveridge 
systems seem to have difficulties at attaining really excellent levels of customer value. The 
largest Beveridge countries, the U.K., Spain and Italy, keep clinging together in the middle of 
the Index. There could be (at least) two different explanations for this: 
1. Managing a corporation or organisation with 100 000+ employees calls for 
considerable management skills, which are usually very handsomely rewarded. 
Managing an organisation such as the English NHS, with close to 1½ million staff, 
who also make management life difficult by having a professional agenda, which 
does not necessarily coincide with that of management/administration, would require 
absolutely world class management. It is doubtful whether public organisations offer 
the compensation and other incentives required to recruit those managers. 
2. In Beveridge organisations, responsible both for financing and provision of 
healthcare, there would seem to be a risk that the loyalty of politicians and other top 
decision makers could shift from being primarily to the customer/patient.  Primary 
loyalty could shift in favour of the organisation these decision makers, with justifiable 
pride, have been building over decades, with justifiable pride, have been building 
over decades (or possibly to aspects such as the job-creation potential of such 
organisations in politicians’ home towns). 
 
2. Introduction 
The Health Consumer Powerhouse (HCP) has become a centre for visions and action 
promoting consumer-related healthcare in Europe. “Tomorrow’s health consumer will not 
accept any traditional borders”, we declared in last year’s report, but it seems that this 
statement is already becoming true; the 2011 EU Directive for patients’ rights to cross-
border care is an excellent example of this trend. In order to become a powerful actor, 
building the necessary reform pressure from below, the consumer needs access to 
knowledge to compare health policies, consumer services and quality outcomes. The Euro 
Health Consumer Indexes are efforts to provide healthcare consumers with such tools. Not 
only do consumers gain from the transparency of benchmarking, the quality and function of 
healthcare systems improve as outcomes are displayed and analysed in an open, systematic, 
and repeated fashion.  
2.1 Background 
Since 2004 the HCP has been publishing a wide range of comparative publications on 
healthcare in various countries. First, the Swedish Health Consumer Index in 2004 (also in an 
English translation). By ranking the 21 county councils by 12 basic indicators concerning the 
design of ”systems policy”, consumer choice, service level and access to information we 
introduced benchmarking as an element in consumer empowerment. In two years time this 
initiative had inspired – or provoked – the Swedish Association of Local Authorities and 
Regions together with the National Board of Health and Welfare to start a similar ranking, 
making public comparisons an essential Swedish instrument for change. 
For the pan-European indexes in 2005 – 2008, HCP aimed to basically follow the same 
approach, i.e. selecting a number of indicators describing to what extent the national 
healthcare systems are “user-friendly”, thus providing a basis for comparing different 
national systems. 
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Furthermore, since 2008 the HCP has enlarged the existing benchmarking program 
considerably: 
 In January 2008, the Frontier Centre and HCP released the first Euro-Canada Health 
Consumer Index, which compared the health care systems in Canada and 29 
European countries. The 2009 edition was released in May, 2009. 
 The Euro Consumer Heart Index, launched in July 2008, compares 29 European 
cardiovascular healthcare systems in five categories, covering 28 performance 
indicators. 
 The first edition of Canada Health Consumer Index was released in September 2008 
in co-operation with Frontier Centre for Public Policy, examining healthcare from the 
perspective of the consumer at the provincial level, and repeated 2009 and 2010. 
 The Euro Consumer Diabetes Index, launched in September 2008, provides the first 
ranking of European diabetes healthcare services across five key areas: Information, 
Consumer Rights and Choice; Generosity, Prevention; Access to Procedures and 
Outcomes. 
 Other Indexes published include the Euro HIV Index 2009, the Euro Headache Index 
2012 and the Euro Hepatitis Index 2012. 
 This year's edition of Euro Health Consumer Index covers 48 healthcare performance 
indicators for 35 countries. 
Though still a somewhat controversial standpoint, HCP advocates that quality comparisons 
within the field of healthcare is a true win-win situation. To the consumer, who will have a 
better platform for informed choice and action. To governments, authorities and providers, 
the sharpened focus on consumer satisfaction and quality outcomes will support change. To 
media, the ranking offers clear-cut facts for consumer journalism with some drama into it. 
This goes not only for evidence of shortcomings and method flaws but also illustrates the 
potential for improvement. With such a view the EHCI is designed to become an important 
benchmark system supporting interactive assessment and improvement.  
As we heard one of the Ministers of health saying when seeing his country’s preliminary 
results: “It´s good to have someone still telling you: you could do better.” 
2.2 Index scope 
The aim has been to select a limited number of indicators, within a definite number of 
evaluation areas, which in combination can present a telling tale of how the healthcare 
consumer is being served by the respective systems. 
2.3 About the author 
Project Management for the EHCI 2014 has been executed by Arne Björnberg, Ph.D., 
Chairman and Chief Operating Officer of the Health Consumer Powerhouse. 
Dr. Björnberg has previous experience from Research Director positions in Swedish industry. 
His experience includes having served as CEO of the Swedish National Pharmacy Corporation 
(”Apoteket AB”), Director of Healthcare & Network Solutions for IBM Europe Middle East & 
Africa, and CEO of the University Hospital of Northern Sweden (“Norrlands 
Universitetssjukhus”, Umeå).  
Dr. Björnberg was also the project manager for the EHCI 2005 – 2013 projects, the Euro 
Consumer Heart Index 2008 and numerous other Index projects. 
 
 ___________________________________________________________ 
23 
 
Euro Health Consumer Index 2014 
3. Countries involved 
In 2005, the EHCI started with a dozen countries and 20 indicators; this year’s index already 
includes all 28 European Union member states, plus Norway and Switzerland, the candidate 
country FYR Macedonia, Albania, Iceland and Serbia, plus Montenegro and Bosnia & 
Herzegovina. 
As an experiment, Scotland, having its own National Health Service, has been separated out 
as a country of its own in the EHCI 2013 - 2014. It is evident from the results (England 718 
points, Scotland 710 points) that separate bureaucracies is not a key to different healthcare 
performance. There also are several areas of healthcare, where regional differences within 
England or Scotland are greater than the differences observed between the two geographies 
taken as separate countries. 
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4. Results of the Euro Health Consumer Index 2014 
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4.1 Results Summary 
In order to help a comparison over time, the Rank numbers ≥ Rank 16 (from UK 
Scotland down) in the Index matrix above do not include Scotland. 
 
Figure 4.1 EHCI 2014 total scores. 
This seventh attempt at creating a comparative index for national healthcare systems 
has confirmed that there is a group of EU member states, which all have good 
healthcare systems seen from the customer/consumer’s point of view. 
The scoring has intentionally been done in such a way that the likelihood that two states 
should end up sharing a position in the ranking is almost zero. It must therefore be 
noted that great efforts should not be spent on in-depth analysis of why one country is 
in 13th place, and another in 16th. Very subtle changes in single scores can modify the 
internal order of countries, particularly in the middle of the ranking list. 
The EHCI 2014 total ranking of healthcare systems shows The Netherlands again 
widening the gap to country #2 from 19 points in 2013 to 43 points in 2014, (in 2012, 
the margin was 50 points), scoring 898 points out of 1000, an EHCI all time high. 
Beginning from Switzerland (855 points) down, the EHCI 2014 shows competition at the 
top getting much harder with no less than 9 countries scoring above 800 points. 
The changes in rank should not at all be dismissed as an effect of changing indicators, 
of which there are 48 in the EHCI 2014, which is the same number as in the previous 
year. The Netherlands is the only country which has consistently been among the top 
three in the total ranking of any European Index the Health Consumer Powerhouse has 
published since 2005. The Netherlands is sub-discipline winner, or joint winner, in four 
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of the six sub-disciplines of the EHCI 2014. The Dutch healthcare system does not seem 
to have any really weak spots in the other sub-disciplines, except possibly some scope 
for improvement regarding the waiting times situation, where some central European 
states excel. Normally, the HCP takes care to state that the EHCI is limited to measuring 
the “consumer friendliness” of healthcare systems, i.e. does not claim to measure which 
European state has the best healthcare system across the board. 
However, the fact that it seems very difficult to build an Index of the HCP type without 
ending up with The Netherlands on the medallists’ podium, creates a strong temptation 
to actually claim that the winner of the EHCI 2014 could indeed be said to have “the 
best healthcare system in Europe”. There should be a lot to learn from looking deeply 
into the Dutch progress! 
Switzerland has for a long time had a reputation for having an excellent healthcare 
system, and it therefore comes as no surprise that the more profound research which 
eliminated most n.a. scores results in a prominent position in the EHCI. 
Bronze medallists are Norway at 851 points; the only country to score All Green on the 
Outcomes indicators. 
Finland (4th) has made a remarkable advance, and seems to have rectified its traditional 
waiting time problems! 
The Swedish score for technically excellent healthcare services is, as ever, dragged 
down by the seemingly never-ending story of access/waiting time problems, in spite of 
national efforts such as Vårdgaranti (National Guaranteed Access to Healthcare); in 
2014, Sweden drops to 12th place with 761 points. 
In southern Europe, Spain and Italy provide healthcare services where medical 
excellence can be found in many places. Real excellence in southern European 
healthcare seems to be a bit too much dependent on the consumers' ability to afford 
private healthcare as a supplement to public healthcare. Also, both Spain and Italy show 
large regional variation, which tends to result in a lot of Amber scores for the countries. 
Some eastern European EU member systems are doing surprisingly well, particularly the 
Czech Republic and Estonia, considering their much smaller healthcare spend in 
Purchasing Power adjusted dollars per capita. However, readjusting from politically 
planned to consumer-driven economies does take time. 
Consumer and patient rights are improving. In a growing number of European countries 
there is healthcare legislation explicitly based on patient rights and a functional access to 
your own medical record is becoming standard. Hospital/clinic catalogues with quality 
ranking used to be confined to two – three countries for years; the 2014 number of nine 
countries hopefully is a sign that something is happening in this area. Medical travel 
supported by the new patient mobility directive can accelerate the demand for 
performance transparency. After the cross-border directive, the criteria for this indicator 
have been tightened to reflect the implementation of this directive. Not unexpectedly, in 
2013 the only countries to score Green were The Netherlands and Luxembourg, who 
have been allowing cross-border care seeking for years. 
Generally European healthcare continues to improve but medical outcomes statistics is 
still appallingly poor in many countries. This is not least the case regarding the number 
one killer condition: cardiovascular diseases, where data for one very vital parameter; 
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30-day case fatality for hospitalized heart infarct patients, had to be compiled from 
several disparate sources. 
If healthcare officials and politicians took to looking across borders, and to "stealing" 
improvement ideas from their European colleagues, there would be a good chance for a 
national system to come much closer to the theoretical top score of 1000. As a 
prominent example; if Sweden could achieve a Belgian waiting list situation, that alone 
would suffice to lift Sweden to compete with The Netherlands at ~880 points! 
A further discussion on results of states and the changes observed over time can be 
found in Chapter 6: Important trends over the six years. 
4.1.1 Country scores 
There are no countries, which excel across the entire range of EHCI indicators. The 
national scores seem to reflect more of “national and organisational cultures and 
attitudes”, rather than mirroring how large resources a country is spending on 
healthcare. The cultural streaks have in all likelihood deep historical roots. Turning a 
large corporation around takes a couple of years – turning a country around can take 
decades! 
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4.1.2 Results in “Hexathlon” 
The EHCI 2014 is made up of six sub-disciplines. As no country excels across all aspects of measuring a healthcare system, it can therefore be of 
interest to study how the 37 countries rank in each of the five parts of the “pentathlon”. The scores within each sub-discipline are summarized in the 
following table: 
 
As the table indicates, the total top position of the Dutch healthcare system is to a great extent a product of an even performance across the sub-
disciplines, very good medical quality improved Accessibility, which used to be a weaker point in previous years. 
Runner-up Switzerland is in top position for Accessibility. with Belgium. No country scores All Green on Outcomes. The Swedish healthcare system 
would be a real top contender, scoring All Green on Range & Reach of Services along with the NL, were it not for an accessibility situation, which by 
Belgian or Swiss standards can only be described as abysmal.  
 
Sub-discipline Top country/countries Score Maximum score 
1. Patient rights and 
information 
Netherlands 146 150 
2. Accessibility Belgium, Switzerland 225! 225 
3. Outcomes Netherlands, Norway 240 250 
4. Range and reach of services  Netherlands, Sweden 150! 150 
5. Prevention Iceland, Norway, Spain, Sweden 107 125 
6. Pharmaceuticals Finland, Germany, Ireland, Netherlands, UK England and Scotland 86 100 
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5. Bang-For-the-Buck adjusted scores 
With all 28 EU member states and eight other European countries included in the EHCI 
project, it becomes apparent that the Index tries to compare states with very different 
financial resources. The annual healthcare spending, in PPP-adjusted (Purchasing Power 
Parity) US dollars, varies from less than $600 in Albania to around $6000 in Norway, 
Switzerland, and Luxembourg. Continental Western Europe and Nordic countries 
generally fall between $3000 and $5000. As a separate exercise, the EHCI 2013 has 
added a value for money-adjusted score: the Bang-For-the-Buck adjusted score, or “BFB 
Score”. 
 
5.1 BFB adjustment methodology 
It is not obvious how to do such an adjustment. If scores would be adjusted in full 
proportion to healthcare spend per capita, the effect would simply be to elevate all less 
affluent states to the top of the scoring sheet. This, however, would be decidedly unfair 
to the financially stronger states. Even if healthcare spending is PPP (Purchasing Power 
Parity) adjusted, it is obvious that also PPP dollars go a lot further to purchase 
healthcare services in member states, where the monthly salary of a nurse is € 200, 
than in states where nurse’s salaries exceed € 3500. For this reason, the PPP adjusted 
scores have been calculated as follows: 
Healthcare spends per capita in PPP dollars have been taken from the WHO HfA 
database (April 2014; latest available numbers, almost all 2012) as illustrated in the 
graph below: 
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For each country has been calculated the square root of this number. The reason for 
this is that domestically produced healthcare services are cheaper roughly in proportion 
to the healthcare spend. The basic EHCI scores have been divided by this square root. 
For this exercise, the basic scoring points of 3, 2 and 1 have been replaced by 2, 1 and 
0. In the basic EHCI, the minimum score is 333 and the maximum 1000. With 2, 1 and 
0, this does not (or only very marginally) change the relative positions of the 37 
countries, but is necessary for a value-for-money adjustment – otherwise, the 333 “free” 
bottom points have the effect of just catapulting the less affluent countries to the top of 
the list. 
The score thus obtained has been multiplied by the arithmetic means of all 37 square 
roots (creating the effect that scores are normalized back to a similar numerical value 
range to the original scores). 
 
5.2 Results in the BFB Score sheet 
The outcome of the BFB exercise is shown in the graphic below. Even with the square 
root exercise described in the previous section, the effect is to dramatically elevate many 
less affluent nations in the scoring sheet. 
 
The BFB scores, naturally, are to be regarded as somewhat of an academic exercise. Not 
least the method of adjusting to the square root of healthcare spent certainly lacks 
scientific support.  
With the great score increase on reduced Waiting Times, FYR Macedonia is absolutely 
unstoppable in this exercise in 2014! Estonia has always been doing well in this analysis, 
and is now joined by Finland; Iceland has been well positioned since it was first 
included. It does seem that the supreme winner in the 2007 and 2008 BFB scores, 
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Estonia, keeps doing well within its financial capacity. It might be that the “steel bath” 
forced upon Estonia after the financial crisis helped cement the cost-effective streaks of 
Estonian healthcare.  
For The Netherlands, the increase in healthcare spend is dragging down the BFB score 
compared with previous years. Portugal is definitely advancing in the BFB league. 
Czech Republic and Croatia were doing well in the BFB Index already in 2012. The good 
positions of the Czech Republic and Croatia in the BFB sheet are probably not just 
artifacts; The Czech Republic seems to have a degree of fundamental stability and 
freedom from corruption in its healthcare system, which is relatively rare in CEE states. 
Croatia does have “islands of excellence” in its healthcare system, and might well 
become a popular country for “health tourism”; there are few other places where a 
state-of-the-art hip joint operation can be had for €3000. 
One thing the authors find interesting is to see which countries top the list in the BFB 
Scores, and also do reasonably well in the original scores. Examples of such countries 
are primarily Finland, Iceland and The Netherlands.  
 
6. Trends over the eight years 
EHCI 2005 was a pilot attempt with only 12 countries and 20 indicators, and is hence 
not included in the longitudinal analysis. 
In the responses on “Single Country Score Sheets” received from national bodies 
(ministries of health) in 2013, there was an unprecedented number of references to 
formal legislation as arguments for a higher score. A typical example was on indicator 
6.4 “Time lag between registration of a drug and inclusion in subsidy system”, where 
several countries referring to legislation saying that the legal time limit for this is 180 
days as an argument for an Amber score. In the EHCI, legislation as such is not the 
basis for an indicator score, as real life often shows significant implementation gaps for 
rules and regulations. 
 
6.1 Score changes 2006 - 2014 
From the point of view of a healthcare consumer, the overall situation is improving in 
most countries. However, not least after the introduction of nine new indicators in the 
2012 index and a further seven new indicators in 2013, there are some countries which 
survive those extra tests on their healthcare systems, and some which suffer in the 2014 
scores. 
Among the “survivors” are the Netherlands, Switzerland, Norway, Iceland, Denmark, 
Belgium, Finland and Latvia. Among countries suffering in 2012 were Austria, Germany, 
Italy and Spain. However, as the “country trends” graph below is showing, the “shock-
induced(?) grumpiness displayed in the survey responses from a number of patient 
organisations in 2012 seemed to have been relieved to a great extent in 2013. The most 
obvious example is Germany, made a giant rebound in 2013 from the deep dive it took 
in 2012, when patient organisations gave unexpectedly negative responses to the survey 
forming part of EHCI data. 
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A feature, which is more prominent in post-crisis 2014 than in previous years is a 
stratification between affluent and less affluent countries. After sovereign winners 
Netherlands, there is a cluster of 8 WE countries. These are followed by Austria, France 
and Sweden, wealthy countries which “do not quite make it” for different reasons. Below 
these three is a mid-section containing countries such as the three “Big Beveridge”; UK, 
Italy and Spain, together with the best of CEE, the Czech Republic and also “climber of 
the year”, the FYR Macedonia. Another relative newcomer in this group is Portugal, 
which has been doing consistently well in recent years, reaching 13th place in 2014. 
There is also a noticeable gap separating the mid-section from countries having a 
greater improvement potential; mainly CEE countries. This is a more obvious correlation 
with national wealth than has been observed in previous EHCI editions, which supports 
the hypothesis that the financial crisis has created a more noticeable “equity gap” for 
healthcare services in rich and poor European countries. 
However, the performance of countries such as Portugal and FYR Macedonia shows that 
GDP/capita need not be a dominating factor. Outside Europe, this is proven by a country 
such as Cuba. 
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 Figure 6.1. The results over the eight years 2006 – 2014.  
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6.1.1 Ranking strictly relative – a lower position does not necessarily mean 
deterioration of services 
The fact that most countries show an upward trend in this normalized calculation can be 
taken as an indication that European healthcare is indeed improving over time. That 
some countries have a downward trend among other countries cannot be interpreted in 
the way that their healthcare systems have become worse over the time studied – only 
that they have developed less positively than the European average!  
6.2 Closing the gap between the patient and professionals 
 
Figure 6.2 The scores have been re-weighted to a maximum of 175, as was the case in 2012. 
More and more states are changing the basic starting point for healthcare legislation, 
and there is a distinct trend towards expressing laws on healthcare in terms of rights of 
citizens/patients instead of in terms of (e.g.) obligations of providers (see section 
describing the indicator Healthcare law based on Patients' Rights). By 2013, only 2 out 
of 34 countries had not introduced healthcare legislation based on Rights of patients: 
Malta and Sweden! From 2015, Sweden will hopefully repair this shortcoming. 
When the indicator on the role of patients’ organisations in healthcare decision making 
was introduced in 2006, no country got a Green score. In 2012, 16 countries scored 
Green, which was a remarkable improvement. In 2014, only in 11 countries do patient 
organisations seem to remember this; a side effect of economic cutbacks? 
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Still, there is a lot to improve: if the patient has to fill in a two-page form and pay EUR 
15 to get access to her own medical record, it sounds more like a bad joke than a 21st 
century approach to patients’ rights (this is an actual example). 
In e-Health, some CEE countries (most notably the FYR Macedonia) have introduced 
applications, which are still rare in Western Europe. This is probably similar to the rapid 
uptake of mobile telephones in India – sometimes, it can be an advantage not to have 
had an ancient technology established. 
 
6.3 Healthcare Quality Measured as Outcomes 
For a detailed view of the results indicators, please see section 8.10.3 in order to study 
development over time. Generally it is important to note that regardless of financial 
crises and austerity measures, treatment results in European healthcare keep 
improving. Perhaps the best single indicator on healthcare quality, 3.3 Infant deaths, 
where the cut-offs between Red/Amber/Green scores have been kept constant since 
2006, shows an increase in the number of Green scores from 9 in 2006 to 22 in 2014, 
(plus Scotland). The figure below shows the “healthcare quality map” of Europe based 
on the Outcomes sub-discipline scores in EHCI 2014: 
 
This map is also remarkably constant over time. Some CEE countries which were 
definitely Red in 2006 have climbed into Amber scores, and Germany, which used to 
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score Amber is today safely in the Green territory. Ireland and Belgium have also got 
their quality acts together.  
That Spain, Italy and the UK (“Big Beveridge”) are still Amber is probably due to large 
regional variation; all three countries most certainly have many centres of excellence in 
healthcare, but the national scores tend to be a rather bleaker Yellow. (UK England 
actually scores Amber on all but one of the Outcomes indicators in 2014.) 
6.3.1 The LAP indicator – money can buy better outcomes! 
Even though the “Big Beveridge” states do less well than their Bismarck colleagues, 
there seems to be a definite correlation between money spent and medical treatment 
results, as is shown by the Graph below: 
 
Figure 6.3.1. The correlation between Outcomes and money spent is quite strong! 
There probably are several reasons why money can buy better outcomes, apart from the 
obvious of affording top experts and state-of-the-art technical facilities. Another reason 
seems to be that more generous funding allows for admitting patients on weaker 
indications. This can be shown by the “Level of Attention to the Problem” (LAP) 
indicator, one illustration of which is found in the Graph below. The graph shows the 
relation between “the ratio of hospital discharges over deaths for heart disease” and the 
per capita healthcare spend. If the ratio of hospital discharges over deaths is high, it 
would indicate that patients are admitted on weaker indications. 
The correlation is noticeable. Also noticeable is the interesting fact that crisis-stricken 
Greeks cannot only afford lots of drugs (see Section 1.4.6), but can somehow afford to 
be very generous on cardiac care hospital admissions in relation to their official 
healthcare spend numbers! 
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Figure 6.3.2. An example of the LAP indicator. 
6.4 Transparent monitoring of healthcare quality 
In 2005, Dr. Foster of the UK was the single shining star on the firmament of provider 
(hospital) listing, where patients could actually see which hospitals had good results in 
term of actual success rates or survival percentages. 
In 2007, there were already a couple more examples, where the Health Consumer 
Powerhouse believes that the most notable is the Danish www.sundhedskvalitet.dk, 
where hospitals are graded from  to  as if they were hotels, with service 
level indicators as well as actual results, including case fatality rates on certain 
diagnoses. Perhaps the most impressive part of this system is that it allows members of 
the public to click down to a link giving the direct-dial telephone number of clinic 
managers. 
Germany did join the limited ranks of countries (today eight, not counting Scotland 
separately!) scoring Green by the power of the public institute BQS, www.bqs-institut.de 
, which also provides results quality information on a great number of German hospitals. 
Possibly, this could be a small part of the reason why German healthcare quality in 2013 
is safely in the “Green territory” (see above). 
Estonia, The Netherlands, Norway, Portugal and Slovakia have joined the ranks of 
countries providing this information to the public. We can also find not-so-perfect, but 
already existing,  catalogues with quality ranking in Cyprus, Hungary, FYR Macedonia, 
Italy (regional; Tuscany et al.) and Slovenia! In France, the HCP team still have not 
found any other open benchmark than the weeklies Le Point and Figaro Magazine 
annual publishing of “The best clinics of France”. As French patient organisations were 
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top of Europe at knowing about this service, France gets a Green score on the strength 
of this. 
Ministry sources of FYR Macedonia claim that they will shortly begin publishing lists of 
“the 100 best doctors”. That will be most interesting to follow, not least from a 
methodology standpoint! Publishing results at individual physician level is also starting in 
the UK! 
6.5 Layman-adapted comprehensive information about 
pharmaceuticals 
In a discussion as late as January 2007, a representative of the Swedish Association of 
Pharmaceutical Industry (LIF), who were certainly pioneers with their well-established 
pharmacopoeia “Patient-FASS” (www.fass.se), was arguing that this and its Danish 
equivalent were the only examples of open information about prescription drugs in 
Europe. Today, easy-to-use web-based instruments to access information on 
pharmaceuticals can be found in 25 countries (see Section 8.15.6, indicator 6.2), also in 
CEE countries, e.g. Czech Republic, Estonia, Hungary, Romania, and Slovakia. The vast 
majority of these information sites have information providers clearly identifiable as the 
pharmaceutical manufacturers. It seems likely that this indicator might cease to be of 
comparative interest in a year or two! 
6.6 Waiting lists: A Mental Condition affecting healthcare 
staff? 
Over the years, one fact becomes clear: gatekeeping means waiting. Contrary to popular 
belief, direct access to specialist care does not generate access problems to specialists 
by the increased demand; repeatedly, waiting times for specialist care are found 
predominately in systems requiring referral from primary care, which seems to be rather 
an absurd observation. 
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Figure 6.6a. “Waiting time territory” (red) and Non-wait territory (green) based on EHCI 2014 
scores. 
The “waiting time territory” situation is remarkably stable over time. However, in 2014 
there seem to have been improvement in some countries such as Finland, Denmark, 
Norway, Portugal, Estonia and Latvia. 
There is virtually no correlation between money and Accessibility of healthcare system, 
as is shown by the Graph below. This could explain the limited effect of showering a 
billion euros over Swedish counties to make them reduce waiting times. 
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Figure 6.6b. Any correlation coefficient (R) lower than 50 % means essentially no correlation. 
It seems that waiting times for healthcare services are a mental condition affecting 
healthcare administrators and professionals rather than a scarcity of resources problem. 
It must be an interesting behavioural problem to understand how an empathic 
profession such as paediatric psychiatrists can become accustomed to telling patients 
and their parents that the waiting time for an appointment is in the order of 18 months 
for a child with psychiatric problems (a common occurrence in Sweden)! 
The Swedish queue-shortening project, on which the state government has spent 
approximately one billion euro, has achieved some shortening of waiting times. Sadly, 
that improvement, which unfortunately does not seem to have succeeded on waiting 
times for cancer treatment, still in 2014 has been insufficient to make Sweden leave the 
group of laggard countries. 
One of the most characteristic systems for GP gatekeeping, the NHS in the UK, spent 
millions of pounds, starting in 2008, on reducing waiting and introduced a maximum of 
18 weeks to definitive treatment after diagnosis. The patient survey commissioned by 
the HCP for the 2012 and 2013 Indices did show improvement, some of which seems to 
have been lost in 2014. 
This is different from Ireland, where patient organisation survey responses are still much 
more negative than (the very detailed) official waiting time data. For this reason, after 
several years of accepting official Irish waiting time statistics, the EHCI 2014 has scored 
Ireland on patients’ versions of waiting times. 
Furthermore, even the strong winners of past years’ rankings have been turning to 
restrictive measures: France, for example, was restraining access in 2007, which 
resulted in waiting times, and therefore worse score (together with not really brilliant 
results in the e-Health sub-discipline). Since 2009, French patients (and doctors?) seem 
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to have learned to work the new regulations, as the French survey responses on this 
sub-discipline are today more positive. Also, about French waiting times in healthcare, 
see Appendix 1! 
HCP will continue to advocate the free choice, equal and direct access and measures 
intended to diminish the information handicap of the consumer as cornerstones of 21st 
century modern European healthcare. 
6.6.1 The “good old days” that never were! 
Why are the traces of the “financial crisis” so comparatively modest,particularly 
regarding medical treatment results (Outcomes)? One fundamental reason is that 
healthcare traditionally used to be very poor at monitoring output, which leads 
healthcare staff, politicians and the public to overestimate the service levels of 
yesteryear! 
Cost-cutting in healthcare was not talked about much until the early 1990’s, and the 
economic downturn at that time, which forced serious cost-cutting more or less for the 
first time in decades. Before 1990, healthcare politicians’ main concern used to be “How 
do we prioritize the 2 – 3% annual real-term increase of resources?” 
In waiting time territory such as Scandinavia and the British Isles, the waiting list 
situation was decidedly worse not only 5 – 10 years ago, but most certainly also before 
1990. Interviews with old-timer doctors and nurses frequently reveal horror stories of 
patients all over corridors and basements, and this from the “good old days” before the 
financial crisis. 
6.6.2 Under-the-table payments 
Even more notable: one of the indicators, introduced for the first time in 2008, is asking 
whether patients are expected to make informal payments to the doctor in addition to 
any official fees. Under-the-table payments serve in some (rather surprising Western 
European) countries as a way to gain control over the treatment: to skip the waiting list, 
to access excellence in treatment, to get benefit of modern methods and medicines. 
More on informal payments can be found in the section Informal payments to doctors. 
The cross-European survey on informal payments remains, in spite of its obvious 
imperfections, the only study ever done on all of Europe, which also illustrates the low 
level of attention paid by nations and European institutions to the problem of parallel 
economy in healthcare. 
This observation gives reason for two questions: 
1. Unlike other professionals, such as airline pilots, lawyers, systems engineers etc, 
working for large organisations, doctors are unique in being allowed to run side 
jobs without the explicit permission of the main employer. What is the reason(s) 
for keeping that? 
2. What could be done to give doctors “normal” professional employment 
conditions, i.e. a decent salary and any extra energy spent on working harder 
(yes, and making more money) for their main employer, instead of disappearing 
to their side practices, frequently leaving large hospitals standing idle for lack of 
key personnel? 
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6.7 Why do patients not know? 
Each year, the results of the survey made in co-operation with Patient View reveal an 
interesting fact: in some countries, the patients’ organisations and health campaigners 
(even very respectful ones) do not know about some of the services available in their 
country. Interestingly, this has probably been more evident in 2013 than the rather 
obvious situation in previous years. The Single Country Score Sheets returned from 
national bodies have had as a very common feature that officials have, with a more or 
less irritated vocabulary, pointed out that certain patient rights or information services 
indeed do exist in their country. 
For example, the research team constantly finds negative answers on the existence of 
doctors’ registries, pharmacopoeias, access to medical records etc. in countries where 
HCP researchers can easily find this kind of information even without the knowledge of 
local language. To sum up, probably the reason is that national authorities make 
considerable improvements, but miss out on communicating these to the wide public. As 
healthcare moves from a top-down expert culture into a communication-driven 
experience industry, such a situation must be most harmful to users as well as tax-
payers and systems! 
Three countries, where the opinions of patient organisations are deviating negatively 
from official statistics, are Greece, Ireland and Spain. One example: Spanish regulations 
do give patients the right to read their own patient records – nevertheless, Spanish 
patient organisations returned among the most pessimistic responses to this survey 
question of any of the 37 countries! 
In private industry, it is well known and established knowledge that a product or service, 
be it ever so well designed and produced, needs skilful marketing to reach many 
customers. In the public sector in general, the focus is (at best) on planning and 
production of a service, but there is frequently an almost total lack of focus on the 
information/marketing of that service. 
European healthcare needs to increase its focus on informing citizens about 
what services are available! 
6.8 MRSA spread 
In the EHCI 2007, considerable attention was paid to the problem of antibiotics 
resistance spread: “MRSA infections in hospitals seem to spread and are now a 
significant health threat in one out of two measured countries.” Unfortunately, the only 
countries where significant improvement can be seen are Bulgaria, Poland and the 
British Isles. Only seven countries out of 35 today can say that MRSA is not a major 
problem, thus scoring Green – rather depressingly, these are the same seven countries 
as in 2009! 
The most dramatic reduction of MRSA rates has taken place in the UK, where the % of 
resistant infections has dropped from > 40 % down to ~15 %. This must be a result of 
intense efforts in hospital hygiene, as the British Isles are still among the most 
pronounced over-users of antibiotics, according to pharmaceutical industry sales 
numbers. 
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6.8.1 Ban sales of antibiotics without prescription! 
There is one measure, which could be very effective against the spread of microbial 
resistance; the banning of sales of antibiotics without a prescription. This could become 
an easily formulated EU directive, which also would be quite simple to monitor, as all 
countries do have systems to check the distinction between Rx (prescription) and OTC 
(Over The Counter) drug sales. There is no country, where sales of antibiotics without a 
prescription is commonplace, which does not have a significant resistance problem! 
Such Brussels action would mean far more to patient safety than most other things EU 
engages in! 
 
 
7. How to interpret the Index results? 
The first and most important consideration on how to treat the results is: with caution! 
The Euro Health Consumer Index 2014 is an attempt at measuring and ranking the 
performance of healthcare provision from a consumer viewpoint. The results definitely 
contain information quality problems. There is a shortage of pan-European, uniform set 
procedures for data gathering. Still, European Commission attempts to introduce 
common, measurable health indicators have made very little impact. As the Commission 
now moves ahead to develop approaches to assess the performance of national 
healthcare systems, there further challenges to tackle.  
Again, the HCP finds it far better to present the results to the public, and to promote 
constructive discussion rather than staying with the only too common opinion that as 
long as healthcare information is not a hundred percent complete it should be kept in 
the closet. Again, it is important to stress that the Index displays consumer information, 
not medically or individually sensitive data. 
While by no means claiming that the EHCI 2013 results are dissertation quality, the 
findings should not be dismissed as random findings. The Index is built from the bottom 
up – this means that countries who are known to have quite similar healthcare systems 
should be expected not to end up far apart in the ranking. This is confirmed by finding 
the Nordic countries in a fairly tight cluster, England and Scotland clinging together as 
are the Czech Republic and Slovakia, Spain and Portugal, Greece and Cyprus. 
Previous experience from the general Euro Health Consumer Indexes reflects that 
consumer ranking by similar indicators is looked upon as an important tool to display 
healthcare service quality. The HCP hopes that the EHCI 2013 results can serve as 
inspiration for how and where European healthcare can be improved.  
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8. Evolvement of the Euro Health Consumer Index 
8.1 Scope and content of EHCI 2005 
Countries included in the EHCI 2005 were: Belgium, Estonia, France, Germany, Hungary, 
Italy, the Netherlands, Poland, Spain, Sweden, the United Kingdom and, for comparison, 
Switzerland. 
To include all 25 member states right from the start would have been a very difficult 
task, particularly as many memberships were recent, and would present dramatic 
methodological and statistic difficulties 
The EHCI 2005 was seeking a representative sample of large and small, long-standing 
and recent EU membership states. 
The selection was influenced by a desire to include all member states with a population 
of ~40 million and above, along with the above-mentioned mix of size and longevity of 
EU membership standing. As the Nordic countries have fairly similar healthcare systems, 
Sweden was selected to represent the Nordic family, purely because the project team 
members had a profound knowledge of the Swedish healthcare system. 
As already indicated, the selection criteria had nothing to do with healthcare being 
publicly or privately financed and/or provided. For example, the element of private 
providers is specifically not at all looked into (other than potentially affecting access in 
time or care outcomes). 
One important conclusion from the work on EHCI 2005 was that it is indeed possible to 
construct and obtain data for an index comparing and ranking national healthcare 
systems seen from the consumer/patient’s viewpoint. 
8.2 Scope and content of EHCI 2006 – 2013 
The EHCI 2006 included all the 25 EU member states of that time plus Switzerland, 
using essentially the same methodology as in 2005. 
The number of indicators was also increased, from 20 in the EHCI 2005 to 28 in the 
2006 issue. The number of sub-disciplines was kept at five; with the change that the 
“Customer Friendliness” sub-discipline was merged into “Patient Rights and 
Information”. The new sub-discipline “Generosity” (What is included in the public 
healthcare offering?) was introduced, as it was commented from a number of observers, 
not least healthcare politicians in countries having pronounced waiting time problems, 
that absence of waiting times could be a result of “meanness” – national healthcare 
systems being restrictive on who gets certain operations could naturally be expected to 
have less waiting list problems. 
In order to test this, the new sub-discipline “Generosity” of public healthcare systems, in 
2009 called “Range and reach of services”, was introduced. A problem with this sub-
discipline is that it is only too easy to land in a situation, where an indicator becomes 
just another way of measuring national wealth (GDP/capita). The suggested indicator 
“Number of hip joint replacements per 100 000 inhabitants” is one prominent example 
of this. The cost per operation of a hip joint is in the neighbourhood of € 7000 (can be 
more in Western Europe – less in states with low salaries for healthcare staff). That 
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cost, for a condition that might be crippling but not life-threatening, results in provision 
levels being very closely correlated to GDP/capita. 
Cataract operations seem a better and less GDP-correlated indicator on the Generosity 
of public healthcare systems. The cost per operation is only one tenth of that for a hip 
joint and thus much more affordable in less affluent countries.  
To achieve a higher level of reliability of information, one essential work ingredient has 
been to establish a net of contacts directly with national healthcare authorities in a more 
systematic way than was the case for previous EHCI editions. The weaknesses in 
European healthcare statistics described in previous EHCI reports can only be offset by 
in-depth discussions with key personnel at a national healthcare authority level. 
In general, the responsiveness from Health Ministries, or their state agencies in charge 
of supervision and/or Quality Assurance of healthcare services, was good in 2006 – 
2008. Written responses were received from 19 EU member states. This situation greatly 
improved in 2009 – 2012 and stayed very positive in 2013 (see section 8.9.2). 
 
8.3 EHCI 2014 
The project work on the Index is a compromise between which indicators were judged 
to be most significant for providing information about the different national healthcare 
systems from a user/consumer’s viewpoint, and the availability of data for these 
indicators. This is a version of the classical problem “Should we be looking for the 100-
dollar bill in the dark alley, or for the dime under the lamppost?” 
It has been deemed important to have a mix of indicators in different fields; areas of 
service attitude and customer orientation as well as indicators of a “hard facts” nature 
showing healthcare quality in outcome terms. It was also decided to search for 
indicators on actual results in the form of outcomes rather than indicators depicting 
procedures, such as “needle time” (time between patient arrival to an A&E department 
and trombolytic injection), percentage of heart patients trombolysed or stented, 
etcetera. 
Intentionally de-selected were indicators measuring public health status, such as life 
expectancy, lung cancer mortality, total heart disease mortality, diabetes incidence, etc. 
Such indicators tend to be primarily dependent on lifestyle or environmental factors 
rather than healthcare system performance. They generally offer very little information 
to the consumer wanting to choose among therapies or care providers, waiting in line 
for planned surgery, or worrying about the risk of having a post-treatment complication 
or the consumer who is dissatisfied with the restricted information. 
 
8.3.1 Two indicators taken out from the EHCI 2013 set  
Of the totally 48 indicators used for the EHCI 2013, two been discontinued in the 2014 
Index: “Undiagnosed Diabetes” and “Sugar Intake”. 
Undiagnosed Diabetes was taken out when it was found that the data from the IDF 
Diabetes Atlas consisted only of applying a factor 0f 0.34 (34%) on the national diabetes 
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prevalence rates, i.e. the indicator contained no additional information. (A couple of 
countries were given the factor 0.303 applied to the diabetes prevalence. 
Sugar Intake was discontinued as the Expert Panel discussion ended with very little 
evidence that the indicator could be linked to health status. 
Despite frenetic disagreement from some countries, HCP proudly keeps the indicator 
“Direct access to specialists” in the EHCI, as there is absolutely no evidence that the GP 
gatekeeping role has an impact on healthcare costs. Studies such as that made by 
Kroneman et al.12 provide more respectful reasoning in this regard than statements like 
“The gatekeeping is a matter of policy and we insist that this indicator is removed from 
the index.” 
Also, the example of Germany shows that the effective way to make patients want to go 
first to their primary care doctor before seeking specialist attention is to establish long-
term relationship and trust between patient and doctor. Restrictions on direct access to 
specialist functions very poorly. 
8.3.2 New indicators introduced for EHCI 2014 
In the design and selection of indicators, the EHCI has been working on the following 
three criteria since 2005: 
1. Relevance 
2. Scientific soundness 
3. Feasibility (i.e. can data be obtained) 
Those same three principles are also governing the German quality indicators project, 
www.bqs-institut.de/. 
As every year the international expert panel has fed in a long list of new indicators to be 
included in this year’s Index (find more on expert panel composition), there was a true 
brainstorm of new bright ideas to be included in this year’s Index. Unfortunately, the 
research team was unable to turn all of them into a green-yellow-red score in the 
matrix. The research team was able to present data for 3 new and one modified 
indicator, and only two indicators have been discontinued, keeping the total 
number of indicators at 48. 
For description and more details on the indicators, see section 8.10 Content of indicators 
in the EHCI 2013. 
Sub-discipline 1 (Patient rights, information and e-Health) 
This sub-discipline is the same as in 2013. 
Sub-discipline 2 Accessibility (waiting times) 
This sub-discipline is the same as in 2013. 
Sub-discipline 3 (Outcomes) – new indicators: 
                                           
12 Kroneman et al: Direct access in primary care and patient satisfaction: A European study. Health Policy 76 
(2006) 72–79. 
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Indicator 3.1 which used to be “Case Fatality Rate for acute heart infarct” has been 
replaced by “Steepness of the trend line of deaths rates for heart disease”. A similar 
indicator (3.2) has been added for stroke death rates. 
Sub-discipline 4 (Range and Reach of services provided) –  no new indicators, 
but 
4.8 Caesarean section rates 
has been moved here from sub-discipline Outcomes. 
Sub-discipline 5 (Prevention) – new indicators: 
5.7 Traffic deaths 
Sub-discipline 6 (Pharmaceuticals) – new indicators: 
This sub-discipline is the same as in 2013, except: 
 the indicator Deployment rate of antipsychotics has been replaced by 
Deployment rate of metformin for diabetics 
 a novel data source has been used for 6.7 Antibiotics consumption. 
 
8.4 Indicator areas (sub-disciplines) 
The 2013 Index is, just like previous EHCI editions, built up with indicators grouped in 
six (this number has varied) sub-disciplines.  
The EHCI 2013 was given a sixth sub-discipline, Prevention, as many interested parties 
(both ministries and experts) have been asking for that aspect to be covered in the 
EHCI. One small problem with Prevention might be that many preventive measures are 
not necessarily the task of healthcare services. The Index at least tries to concentrate on 
such aspects of Prevention, which can be affected by human decision makers in a 
reasonably short time frame. 
After having had to surrender to the “lack of statistics syndrome”, and after scrutiny by 
the expert panel, 48 indicators survived into the EHCI 2014. 
The indicator areas for the EHCI 2014 are: 
Sub-discipline Number of indicators 
1. Patient rights and information 12 
2. Accessibility/Waiting time for treatment 6 
3. Outcomes 8 
4. Range and reach of services (“Generosity”) 8 
5. Prevention 7 
6. Pharmaceuticals 7 
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8.5 Scoring in the EHCI 2014 
The performance of the respective national healthcare systems were graded on a three-
grade scale for each indicator, where the grades have the rather obvious meaning of 
Green = good (), Amber = so-so () and red = not-so-good (). A green score 
earns 3 points, an amber score 2 points and a red score (or a “not available”, n.a.) earns 
1 point. 
Having six non-EU countries in the Index, who should not be stigmatized for not (yet) 
being EU member states on indicator “1.8 Free choice of care in another EU state”, 
forced the introduction of a new score in the EHCI 2009: “not applicable”. These 
countries therefore receive the “n.ap.” score, which earns 2 points. That score was also 
applied on indicator 1.9 for Iceland and Malta, as they essentially have only one real 
hospital each. 
In 2013, a Purple score: , earning 0 points, was introduced for particularly 
abominable results. It has been exclusively applied on indicator “3.7 Abortion rates” for 
countries not giving women the right to abortion. 
Since the 2006 Index, the same methodology has been used: For each of the sub- 
disciplines, the country score is calculated as a percentage of the maximum possible 
(e.g. for Waiting times, the score for a state has been calculated as % of the maximum 
3 x 6 = 18).  
Thereafter, the sub-discipline scores were multiplied by the weight coefficients given in 
the following section and added up to make the final country score. These percentages 
were then rounded to a three digit integer, so that an “All Green” score on the 48 
indicators would yield 1000 points. “All Red” gives 333 points. 
8.6 Weight coefficients 
The possibility of introducing weight coefficients was discussed already for the EHCI 
2005, i.e. selecting certain indicator areas as being more important than others and 
multiplying their scores by numbers other than 1.  
For the EHCI 2006, explicit weight coefficients for the five sub-disciplines were 
introduced after a careful consideration of which indicators should be considered for 
higher weight. The accessibility and outcomes sub disciplines were decided as the main 
candidates for higher weight coefficients based mainly on discussions with expert panels 
and experience from a number of patient survey studies. 
In the EHCI 2014, the scores for the five sub-disciplines were given the following 
weights, which are the same as in 2013: 
Sub discipline Relative weight (“All 
Green” score contribution 
to total maximum score of 
1000)  
Points for a Green 
score in each sub-
discipline 
Patient rights, information and 
e-Health 
150 12.50 
Accessibility (Waiting time for 225 37.50 
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treatment) 
Outcomes 250 31.25 
Range and reach of services 
(“Generosity”) 
150 18.75 
Prevention 125 17.85 
Pharmaceuticals 100 14.29 
Total sum of weights 1000   
 
Consequently, as the percentages of full scores were added and multiplied by 
(1000/Total sum of weights), the maximum theoretical score attainable for a national 
healthcare system in the Index is 1000, and the lowest possible score is 333. 
It should be noted that, as there are not many examples of countries that excel in one 
sub-discipline but do very poorly in others, the final ranking of countries presented by 
the EHCI 2014 is remarkably stable if the weight coefficients are varied within rather 
wide limits. 
The project has been experimenting with other sets of scores for green, amber and red, 
such as 2, 1 and 0 (which would really punish low performers), and also 4, 2 and 1, 
(which would reward real excellence). The final ranking is remarkably stable also during 
these experiments. 
 
8.6.1 Regional differences within European states 
The HCP is well aware that many European states have very decentralised healthcare 
systems. Not least for the U.K. it is often argued that “Scotland and Wales have 
separate NHS services, and should be ranked separately”. 
The uniformity among different parts of the U.K. is probably higher than among regions 
of Spain and Italy, Bundesländer in Germany and possibly even than among counties in 
tiny 9½ million population Sweden. 
This has been proved by the EHCI 2013 – 2014, which include the experiment of 
separating out Scotland. Scotland and England end up close at 710 and 718 points out 
of 1000 respectively; the two countries actually have slightly different scores on 11 out 
of 48 indicators, still with this net result. It was also observed that regional differences 
within England are greater than the differences between England and Scotland. 
Grading healthcare systems for European states does present a certain risk of 
encountering the syndrome of “if you stand with one foot in an ice-bucket and the other 
on the hot plate, on average you are pretty comfortable”. Particularly Italy seems to be 
a victim of that syndrome, ending up with a large number of Yellow scores made up by 
some regions in reality scoring Green and others scoring Red. This problem would be 
quite pronounced if there were an ambition to include the U.S.A. as one country in a 
Health Consumer Index. 
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As equity in healthcare has traditionally been high on the agenda in European states, it 
has been judged that regional differences are small enough to make statements about 
the national levels of healthcare services relevant and meaningful.
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8.7 Indicator definitions and data sources for the EHCI 2014 
It is important to note, that since 2009, the HCP has been receiving much more active feedback from national healthcare agencies in all but a few of the 37 
countries. In those cases, the responses in the survey commissioned from Patient View 2014 have been applied very cautiously, e.g. when the “official” data 
says Green, and the survey says “definitely Red”, the country has been awarded a Yellow score. 
Sub- 
discipline Indicator Comment 

Score 3 
 
Score 2 
 
Score 1 Main Information Sources 
1. Patient 
rights and 
information 
1.1 Healthcare law 
based on Patients' 
Rights 
Is  national HC legislation 
explicitly expressed in 
terms of Patients' rights? 
 Yes Various kinds of 
patient charters 
or similar 
byelaws 
No European Observatory HiT Reports, 
http://europatientrights.eu/about_us.html; Patients' Rights Law (Annex 
1 to EHCI report); http://www.healthline.com/galecontent/patient-
rights-1; 
http://www.adviceguide.org.uk/index/family_parent/health/nhs_patient
s_rights.htm; www.dohc.ie; 
http://www.sst.dk/Tilsyn/Individuelt_tilsyn/Tilsyn_med_faglighed/Skaer
pet_tilsyn_med_videre/Skaerpet_tilsyn/Liste.aspx; 
http://db2.doyma.es/pdf/261/261v1n2a13048764pdf001.pdf. 
http://www.bmg.bund.de/praevention/patientenrechte/patientenrechte
gesetz.html 
1.2 Patient 
organisations 
involved in decision 
making 
  
 Yes, statutory Yes, by 
common 
practice in 
advisory 
capacity 
No, not 
compulsory or 
generally done 
in practice 
Patients' Perspectives of Healthcare Systems in Europe; survey 
commissioned by HCP 2014. Personal interviews. 
1.3 No-fault 
malpractice 
insurance 
Can patients get 
compensation without the 
assistance of the judicial 
system in proving that 
medical staff made 
mistakes? 
 Yes Fair; > 25% 
invalidity 
covered by the 
state 
No Swedish National Patient Insurance Co. (All Nordic countries have 
no1fault insurance); www.hse.ie; www.hiqa.ie. 
1.4 Right to second 
opinion 
   Yes Yes, but difficult 
to access due to 
bad information, 
bureaucracy or 
doctor 
negativism 
 No Patients' Perspectives of Healthcare Systems in Europe; survey 
commissioned by HCP 2014. Personal interviews. 
1.5 Access to own 
medical record 
Can patients read their 
own medical records? 
 Yes, they get a 
copy by simply 
asking their 
doctor(s) 
Yes, but 
cumbersome; can 
require written 
application or only 
access with 
No, no such 
statutory right. 
Patients' Perspectives of Healthcare Systems in Europe; survey 
commissioned by HCP 2014.  Personal interviews; www.dohc.ie. 
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Sub- 
discipline Indicator Comment 

Score 3 
 
Score 2 
 
Score 1 Main Information Sources 
professional 
"walk-though" 
1.6 Registry of bona 
fide doctors 
Can the public readily 
access the info: "Is doctor 
X a bona fide specialist?" 
Yes, on the 
www or in 
widely spread 
publication 
Yes, but in 
publication 
expensive or 
cumbersome to 
acquire 
No Survey commissioned from Patient View by HCP 2014. National 
physician registries.; 
p://www.sst.dk/Tilsyn/Individuelt_tilsyn/Tilsyn_med_faglighed/Skaerpe
t_tilsyn_med_videre/Skaerpet_tilsyn/Liste.aspx; http:// 
1.7 Web or 24/7 
telephone HC info 
with interactivity 
Information which can 
help a patient take 
decisions of the nature: 
“After consulting the 
service, I will take a 
paracetamol and wait and 
see” or “I will hurry to the 
A&E department of the 
nearest hospital” 
 Yes Yes, but not 
generally 
available, or 
poorly marketed 
to the public 
No or sporadic Patients' Perspectives of Healthcare Systems in Europe; survey 
commissioned by HCP 2014. Personal interviews; 
http://www.nhsdirect.nhs.uk/; www.hse.ie; www.ntpf.ie. 
1.8 Cross-border 
care seeking 
financed from home 
Can patients freely choose 
to be treated in another 
EU state? 
Yes; including 
elective in-
patient 
procedures 
Yes, after 
excessive wait 
Yes, with pre-
approval, or 
very limited 
choice (for care 
not given in 
home country) 
Patients' Perspectives of Healthcare Systems in Europe; survey 
commissioned by HCP 2014. Interviews with healthcare officials. 
1.9 Provider 
catalogue with 
quality ranking 
“NHS Choices” in the U.K. 
a typical qualification for a 
Green score. The “750 
best clinics” published by 
LaPointe in France would 
warrant a Yellow. 
 Yes To some extent, 
regional or not 
well marketed to 
the public 
No Patients' Perspectives of Healthcare Systems in Europe; survey 
commissioned by HCP 2014. http://www.drfoster.co.uk/home.aspx; 
http://www.sundhedskvalitet.dk/; 
http://www.sykehusvalg.no/sidemaler/VisStatiskInformasjon____2109
.aspx; http://www.hiqa.ie/; 
http://212.80.128.9/gestion/ges161000com.html. 
1.10 EPR penetration % of GP practices using 
electronic patient records 
for diagnostic data 
≥ 90 % of GP 
practices 
<90 ≥ 50 % of 
practices 
< 50 % of 
practices 
http://ec.europa.eu/public_opinion/flash/fl126_fr.pdf; 
http://www.europartnersearch.net/ist/communities/indexmapconso.ph
p?Se=11; www.icgp.ie; Commonwealth Fund International Health 
Policy Survey of Primary Care Physicians"Benchmarking ICT use 
among GP:s in Europe"; European Commission, April 2008; study 
made by Empirica, Bonn, Germany (p.60), Gartner Group 
1.11 Patients' access 
to on-line booking of 
appointments?  
Can patients book doctor 
appointments on-line? 
Yes, widely 
available 
With some 
pioneer 
hospitals/clinics 
No, or very rare Survey commissioned by HCP from Patient View 2014. Interviews 
with healthcare officials. 
1.12 e-prescriptions   Fully functional 
ePrescription services 
across the country or 
substantial parts of 
certain regions 
Some 
pharmacies 
have this 
service 
No, or very rare. Survey commissioned by HCP from Patient View 2014.Kierkegaard, 
P. (2013), "E-Prescription across Europe". Health and Technology, 3 
(1) Interviews with healthcare officials. 
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Sub- 
discipline Indicator Comment 

Score 3 
 
Score 2 
 
Score 1 Main Information Sources 
2. 
Accessibility 
(waiting times 
for treatment) 
2.1 Family doctor 
same day access 
Can I count on seeing my 
primary care doctor 
today? 
 Yes Yes, but not 
quite fulfilled 
No Survey commissioned from Patient View by HCP 2014. National 
healthcare agencies. 
2.2 Direct access to 
specialist 
Without referral from 
family doctor (GP) 
 Yes Quite often in 
reality, or for 
limited number 
of specialities 
No Survey commissioned by HCP from Patient View 2014. Interviews 
with healthcare officials, feedback from national agencies. 
2.3 Major elective 
surgery <90 days 
Coronary bypass/PTCA 
and hip/knee joint  
 90% <90 days  50 - 90% <90 
days 
 > 50% > 90 
days 
Survey commissioned by HCP from Patient View 2014. Interviews 
with healthcare officials, feedback from national agencies. 
2.4 Cancer therapy < 
21 days 
Time to get radiation/ 
chemotherapy after 
decision 
 90% <21 days  50 - 90% <21 
days 
 > 50% > 21 
days 
Survey commissioned by HCP from Patient View 2014. Interviews 
with healthcare officials, feedback from national agencies. 
www.socialstyrelsen.se: Väntetider cancervård  
2.5 CT scan < 7days Wait for advanced 
diagnostic (non-acute) 
Typically <7 
days 
Typically <21 
days 
Typically > 21 
days 
Survey commissioned by HCP from Patient View 2014. Interviews 
with healthcare officials, feedback from national agencies. 
www.socialstyrelsen.se: Väntetider 
2.6 A&E waiting 
times 
“Waiting time”: the period 
between arrival at the 
hospital door and when a 
doctor starts 
treating/attending the 
problem. 
Typically < 1 
hour 
Typically 1 - 3 
hours 
Typically > 3 
hours 
Survey commissioned by HCP from Patient View 2014. Interviews 
with healthcare officials, feedback from national agencies. 
3. Outcomes 
3.1 Decrease of 
CVD deaths 
Inclination of 
ischaemic heart 
disease death trend 
line (log values) 
Sharp decline Moderate 
decline 
Weak decline WHO HfA database, April 2014 
3.2 Decrease of 
stroke deaths 
Inclination of stroke 
death trend line (log 
values) 
Sharp decline Moderate 
decline 
Weak decline WHO HfA database, April 2014 
3.3 Infant deaths /1000 live births  <4 < 6  ≥6 WHO Europe Health for All mortality database April 2014, latest 
available statistics.  
3.4 Cancer survival 1 minus ratio of 
mortality/incidence 
2012 ("survival rate") 
 ≥ 60 % 59.9 - 50 % < 50 % J. Ferlay et al. / European Journal of Cancer 49 (2013) 1374–1403 
3.5 Preventable 
Years of Life Lost 
All causes, Years 
lost, /100000 
< 4500 4501 - 7000 > 7000 WHO Europe Detailed Mortality Database, May 2014 
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Sub- 
discipline Indicator Comment 

Score 3 
 
Score 2 
 
Score 1 Main Information Sources 
population 
3.6 MRSA 
infections 
Susceptibility results 
for S. aureus 
isolates, % 
 <5%  <20%  >20% ECDC EARS-net, September 2014 (most data 2012) 
3.7 Abortion rates # per 1000 live 
births; low = Good, 
Very low=purple 
< 200 201 - 300 > 300 WHO Health for All Database April 2014, United Nations Information 
on Abortion 
3.8 Depression Average score on 5 
mental health 
questions 
≥ 67 % 66 - 55 % < 55 % Special Eurobarometer 345, October 2011; www.fhi.no "Psykisk helse 
i Norge 2011:2", 
http://worlddatabaseofhappiness.eur.nl/hap_nat/nat_fp.php?mode=8  
4. 
 Range and 
reach of 
services 
provided 
4.1 Equity of 
healthcare 
systems 
Public HC spend as 
% of total HC spend 
≥ 80 % <80 % - >70 % ≤ 70 % WHO HfA database, April 2014 
4.2 Cataract 
operations per 100 
000 age 65+ 
Total number of 
procedures divided 
by 100 000's of pop. 
≥ 65 years 
> 5000 5000 - 3000  < 3000 OECD Health Data 2014, WHO HfA database, WHO Prevention of 
Blindness and Visual Impairment Programme, European Community 
Health Indicators, national data 
4.3 Kidney 
transplants per 
million pop. 
Living and deceased 
donors, procedures 
p.m.p. 
≥ 40 40 - 30  < 30 Council of Europe Newsletter September 2014 
4.4 Is dental care 
included in the 
public healthcare 
offering? 
% of average income 
earners stating unmet 
need for a dental 
examination, 2010 
< 5 % 5 - 9.9 % ≥ 10 % OECD Health at a Glance 2014, Eurostat: 
http://appsso.eurostat.ec.europa.eu/  
4.5 Informal 
payments to doctors 
Mean response to 
question: "Would 
patients be expected to 
make unofficial 
payments?" 
No! Sometimes; 
depends on 
the situation 
Yes, 
frequently 
Survey commissioned from Patient View by HCP 2014. National 
healthcare agencies. 
4.6 Long term care 
for the elderly  
# of nursing home 
and elderly care 
beds per 100 000 
≥ 6000 5999 - 3000 < 3000 WHO HfA database, April 2014 
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Sub- 
discipline Indicator Comment 

Score 3 
 
Score 2 
 
Score 1 Main Information Sources 
population 65+  
4.7 % of dialysis 
done outside of 
clinic  
% of all Dialysis 
patients on PD or HD 
in the home 
≥ 15 % <15 % - 8 % < 8 % European Renal Association Annual Report 2012, www.ceapir.org  
4.8 Caesarean 
sections 
# per 1000 live 
births; low = Good 
pre-natal care 
< 200 201 - 300 > 300 WHO Health for All Database April 2014 
5. Prevention 
5.1 Infant 8-disease 
vaccination 
Tetanus, pertussis, 
poliomyelitis, 
haemophilus influenza 
B, hepatitis B, 
measles,mumps, 
rubella arithmethic 
mean 
≥95 % ≥85 - <95% <85 % WHO HfA database, April 2014, 
http://data.euro.who.int/cisid/?TabID=352277 
5.2 Blood pressure % of people 25+ with 
a blood pressure > 
140/90 
< 25% 25 - 35 % > 35 % WHO World Health Statistics 2014 
5.3 Smoking 
Prevention  
Total score on Tobacco 
Control Scale plus 
Cigarette absolute 
consumption and trend 
line 
≥ 61 60 - 51 ≤ 50 Joossens, L. & Raw, M. "The Tobacco Control Scale 2013"; Cigarette 
consumption data WHO HfA April 2014 
5.4 Alcohol "Binge drinking 
adjusted" alcohol 
intake p.p. 15+ 
< 10 litres pure 
alcohol p.p. 
10 - 13 litres 
pure alcohol 
p.p. 
> 14 litres WHO HfA April 2014, Special Eurobarometer 331 April 2010 
5.5 Physical 
activity 
Hours of physical 
education in 
compulsory school 
≥ 751 750 - 600 < 600 http://eacea.ec.europa.eu/education/eurydice/documents/facts_and_fi
gures/Instruction_Time_2013_14.pdf; www.vsa.zh.ch  
5.6 HPV 
vaccination 
National programme 
for teenage girls 
Yes, free of 
charge to 
patient 
Yes; patient 
pays 
significant part 
No. European Centre for Disease Prevention and Control. Introduction of 
HPV vaccines in EU countries – an update. Stockholm: ECDC; 2012. 
Seme et al.: Acta Dermatovenerologica APA 2013; 22:21-25. 
www.bag.admin.ch/themen/medizin/00682/00684/03853/; feedback 
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Sub- 
discipline Indicator Comment 

Score 3 
 
Score 2 
 
Score 1 Main Information Sources 
of cost from national agencies. 
5.7 Traffic deaths SDR/ 100 000 
population 
< 5 5 - 8 > 8 WHO HfA April 2014 
6. 
Pharmaceu-
ticals 
6.1 Rx subsidy Proportion of total sales of 
pharmaceuticals (OTC 
included) paid for by 
public subsidy 
≥ 70% 69.9 - 50 % < 50% WHO HfA database April 2014, EFPIA: The pharmaceutical industry 
in figures - Key Data 2014 
6.2 Layman-adapted 
pharmacopoeia? 
Is there a layman-adapted 
pharmacopeia readily 
accessible by the public 
(www or widely avaliable)? 
Yes, with a 
visible and 
accountable 
information 
provider 
Yes, but 
difficult to 
know who is 
the information 
provider 
 No Survey commissioned from Patient View by HCP 2013. HCP research 
2010-2013. National Medical Products Agencies. 
6.3 Novel cancer 
drugs deployment 
rate 
ATC code L01XC 
(monoclonal antibodies) 
Use per capita, MUSD 
p.m.p. 
> 15 15 - 10 < 10 IMS MIDAS database, 12 months ending June 2013, 
www.nuffieldtrust.org.uk/data-and-charts/prescribing-spend-person-uk  
6.4 Access to new 
drugs (time to 
subsidy) 
Between registration and 
inclusion in subsidy 
system 
 <150 days  <300 days  >300 days Patients W.A.I.T. Indicator 2011 and 2012 Reports – based on 
EFPIA’s databases 
6.5 Arthritis drugs TNF-α inhibitors, Standard 
Units per capita, 
prevalence adjusted 
> 300 300 - 100 < 100 IMS MIDAS database, eumusc.net: Report v5.0 Musculoskeletal 
Health in Europe (2012), Special Eurobarometer 272 (2007) 
6.6 Metformin use Metformin use; SU 
per diabetic case 
> 400 400 - 250 < 250 IMS MIDAS database, full year 2013 
6.7 Antibiotics/capita  DDD/1000 
inhabitants per day 
≤ 20 20 – 26  ≥ 26  Four-fold difference in antibiotic consumption across the European 
Region – new WHO report 2014-03-17. IMS MIDAS database, 12 
months ending June 2013 
 
Table 8.7: Indicator definitions and data sources for the EHCI 2014
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8.7.1 Additional data gathering - survey 
In addition to public sources, as was also the case for the 2005 - 2013 Indexes, a web-
based survey to Patient organisations was commissioned from PatientView, 
Woodhouse Place, Upper Woodhouse, Knighton, Powys, LD7 1NG, Wales, Tel: 
0044-(0)1547-520-965, E-mail: info@patient-view.com. In 2014, this survey included 
the six Accessibility indicators, two e-Health indicators plus 8 other indicators. The 
survey can be accessed on 
https://www.dropbox.com/s/ae670o9pxm63boj/Survey_55014628.pdf?dl=0  
A total of 665 patient organisations responded to the survey (ganska lågt antal?). The 
lowest number of responses from any single country was 2 (Albania), except from 
Slovakia, from where no responses were obtained; SK has therefore kept its scores from 
2012 on indicators where new information from national ministries or other sources was 
not available. 
Since 2009, the feedback from National Agencies has been a lot better and more 
ambitious than for previous EHCI editions. For that reason, the responses from the PV 
survey have been used very cautiously when scoring the indicators. On any indicator, 
where the HCP has received substantial information from national sources (i.e. 
information including actual data to support a score), the PV survey results have only 
been used to modify the score based on national feedback data, when the PV survey 
responses indicate a radically different situation from that officially reported. 
Consequently, the PV survey has essentially been used as a CUTS data source (see 
section 8.11) only for the waiting time indicators, and for indicator 4.5 Informal 
payments to doctors.  
8.7.2 Additional data gathering – feedback from National Ministries/Agencies 
On October 30th, 2014, preliminary score sheets were sent out to Ministries of Health or 
state agencies of all 37 countries, giving the opportunity to supply more recent data 
and/or higher quality data than what is available in the public domain. 
This procedure had been prepared for during the spring of 2014 by extensive mail, e-
mail, telephone contacts and personal visits to ministries/agencies. Finally, feedback 
responses, in the form of returned “single country score sheets” and/or thorough 
discussions at personal visits to MoH:s/national agencies, have been had from official 
national sources. 
Score sheets sent out to national agencies contained only the scores for that respective 
country. Corrections were accepted only in the form of actual data, not by national 
agencies just changing a score (frequently from Red to something better, but 
surprisingly often honesty prevailed and scores were revised downwards). 
8.8 Threshold value settings 
The performance of national healthcare systems was graded on a three-grade scale for 
each indicator (see more information in Scoring section). 
It has not been the ambition to establish a global, scientifically based principle for 
threshold values to score green, amber or red on the different indicators. Threshold 
levels have been set after studying the actual parameter value spreads, in order to avoid 
having indicators showing “all Green” or “totally Red”. 
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Setting threshold values is typically done by studying a bar graph of country data values 
on an indicator sorted in ascending order. The usually “S”-shaped curve yielded by that 
is studied for notches in the curve, which can distinguish clusters of states, and such 
notches are often taken as starting values  for scores. A slight preference is also given to 
threshold values with even numbers. An illustration of this procedure can be the scoring 
diagram for the indicator 1.10 e-Prescriptions: 
 
Scoring for indicator 1.10. It illustrates the “notches in the S-curve” quite nicely. 
Finally, the HCP is a value-driven organisation. We believe in Patient/Consumer 
Empowerment, an approach that places highest importance on quantitative and 
qualitative healthcare services. As is illustrated by indicator 1.8 Cross-border care, this 
sometimes leads to the inclusion of indicators where rather few countries, theoretically 
none, score Green (in this case only Luxembourg and The Netherlands do). Besides, we 
also find it evident that individuals are better fit to make decisions about their health 
and healthcare than rulings driven by moralistic, religious or paternalistic prejudice. 
 
8.9 “CUTS” data sources 
Whenever possible, research on data for individual indicators has endeavoured to find a 
“CUTS” (Comprehensive Uniform Trustworthy Source). If data on the underlying 
parameter behind an indicator is available for all or most of the 35 countries from one 
single and reasonably reliable source, then there has been a definitive preference to 
base the scores on the CUTS. As CUTS would be considered e.g. ECDC data, WHO 
databases, OECD Health data, Special Eurobarometers or scientific papers using well-
defined and established methodology. 
Apart from the sheer effectiveness of the approach, the basic reason for the 
concentration on CUTS, when available, is that data collection primarily based on 
information obtained from 35 national sources, even if those sources are official Ministry 
of Health or National Health/Statistics agencies, generally yields a high noise level. It is 
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notoriously difficult to obtain precise answers from many sources even when these 
sources are all answering the same, well-defined question. For example, in an earlier 
Index project, it was difficult to ask questions about a well-defined indicator such as 
“SDR of respiratory disease for males >45 years of age”. For one country protesting 
violently against their score, it took three repeats of asking the question in writing 
before the (very well-educated) national representative observed that the indicator was 
for “males 45+” only, not the SDR for the entire population. It has to be emphasized 
that also when a CUTS for an indicator has been identified, the data are still reviewed 
through cross-check procedures, as there have frequently been occasions where 
national sources or scientific papers have been able to supply more recent and/or higher 
precision data. 
8.9.1 The “Rolls-Royce gearbox” factor 
Another reason for preferably using CUTS whenever possible is the same reason why 
Rolls-Royce (in their pre-BMW days) did not build their own gearboxes. The reason was 
stated as “We simply cannot build a better gearbox than those we can get from outside 
suppliers, and therefore we do not make them ourselves”. For the small size 
organisation HCP, this same circumstance would be true for an indicator where a 
Eurobarometer question, the WHO HfA database or another CUTS happens to cover an 
indicator. 
 
8.10 Content of indicators in the EHCI 2014 
The research team of the Euro Health Consumer Index 2014 has been collecting data on 
48 healthcare performance indicators, structured in a framework of six sub-disciplines. 
Each of these sub-disciplines reflects a certain logical entity, e.g. Medical outcomes or 
Accessibility. 
For reader friendliness and clarity, the indicators come numbered in the report. 
Where possible, CUTS - Comprehensive Uniform Trustworthy Sources - were used; see 
section “CUTS Data Sources” for more information on this approach, typical for HCP 
research work. 
 
8.10.1 Patients' Rights and Information 
This sub-discipline is testing the ability of a healthcare system to provide the patient 
with a status strong enough to diminish the information skew walling the professional 
and patient. 
Why does HCP love this sub-discipline? Because it is a GDP non-dependent indicator 
family. Even the poorest countries can allow themselves to grant the patient a firm 
position within the healthcare system; and the 2013 Euro Health Consumer Index is 
proving this observation again. 
There are 12 indicators in this sub-discipline: 
 
1.1 Patients' Rights based healthcare law  
Is  national healthcare legislation explicitly expressed in terms of patients' rights? By law 
or other legislative act? Are there professional ethical codes, patients' charters, etc.? 
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This indicator has been in the EHCI since 2005. As the number of countries not having 
adopted such legislation is now down to three, it might be candidate for replacement in 
2015. 
Sources of data: http://europatientrights.eu/about_us.html ; Patients' Rights Law 
(Annex 1 to EHCI report, used as starting material); updates through European 
Observatory HiT reports, National healthcare agencies, web-based research, journals 
search. Non-CUTS data.  
 
1.2 Patients' Organisations involved in decision making 
Do patient organisations have right to participate in healthcare decision making? 
Sometimes we find that patient's organisations are welcomed to get involved, 
sometimes they do it by law, sometimes they do it only informally, but usually, 
sometimes only formally without a real participation, sometimes not at all. 
Sources of data: Patients' Perspectives of Healthcare Systems in Europe; survey 
commissioned by HCP 2014. National healthcare agencies. European Observatory HiT 
reports. Non-CUTS data.  
 
1.3 No-fault malpractice insurance 
Can patients get compensation without the assistance of the judicial system? Does the 
compensation prerequisite proving who among the medical staff made a mistake? Each 
year, the HCP research staff is meeting high healthcare officials who have never heard 
of no-fault malpractice system, such as that put in place essentially in the Nordic 
countries. However, since 2009, there has been clear development in this area in a 
number of countries. 
Source of data: Swedish National Patient Insurance Co. (All Nordic countries have 
no1fault insurance); www.hse.ie ; www.hiqa.ie . National healthcare agencies, web-
based research, journals search. Non-CUTS data. 
 
1.4 Right to second opinion 
As in other areas of human life, there are not many questions and conditions with only 
one right answer, in medicine also. Therefore, do the patients have the right to get the 
second opinion, without having to pay extra? Is it a formal right, but unusual practice, or 
well-established institute? 
Countries where this right exists on paper, but where patient organisations reveal a low 
degree of knowledge of its existence, have been awarded a Yellow score instead of the 
Green, which the formal situation would have given. 
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Sources of data: Patients' Perspectives of Healthcare Systems in Europe; survey 
commissioned by HCP 2014. National healthcare agencies. Non-CUTS data. 
 
1.5 Access to own medical record 
Can patients readily get access to, and read, their own medical records? Hard to believe, 
at some places in Europe, the patient's personal data and integrity is so protected, that 
she cannot access her own medical record. This is remarkable, as the EU? Data 
protection directive is very clear on the fact that the patient should have this right by 
law. Elsewhere, she cannot access it either, but at least she is not being told it is for her 
own good. However, in recent years, this situation seems to have improved significantly 
in a number of countries! 
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Figure 8.10.1.5. A result of 1.000 means that all respondents of that country answer “Yes”. 3.000 
means all reply “No”. The graph shows that even though patient records are supposed to be 
available to individual patients, this is still not universally known in several countries. 
Sources of data: Patients' Perspectives of Healthcare Systems in Europe; survey 
commissioned by HCP 2014. National healthcare agencies; web and journal research. 
Non-CUTS data.  
 
1.6 Register of legit doctors 
Can the public readily access the information: "Is doctor X a bona fide specialist?" To 
qualify, this has to be a web/telephone based service.. Yellow pages do not score Green 
– with an exception for Luxembourg, where the chapter on physicians is yearly reviewed 
and approved by the Ministry of health. This is a very easy and cheap service to 
implement, but still it is very difficult to find such sources of information. 
Sources of data: Patients' Perspectives of Healthcare Waiting times in Europe; survey 
commissioned by HCP 2014. National physician registries. National healthcare agencies; 
web and journal research. Non-CUTS data. 
 
1.7 Web or 24-7 telephone healthcare info with interactivity 
Simple description of this indicator used in previous years' editions remains the same in 
2013: Information which can help a patient take decisions of the nature: “After 
consulting the service, I will take a paracetamol and wait and see” or “I will hurry to the 
A&E department of the nearest hospital” The most comprehensive service of this kind is 
the British NHS Direct. In 2014, several countries have developed decentralized solutions 
such as “round-the-clock” primary care surgeries, which offer the same service. 
Sources of data: Patients' Perspectives of Healthcare Systems in Europe; survey 
commissioned by HCP 2014. National healthcare agencies, web search. Non-CUTS data. 
 
1.8 Cross-border care seeking financed from home 
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The directive on the application of patients’ rights to cross-border healthcare 
was decided on 2011-03-09. EU countries had until 25 October 2013 to pass their own 
laws implementing the Directive. Therefore, the criteria for scores on this indicator were 
tightened considerably compared with previous ECHI editions. At the time of publication 
of this report (January 2015), some little progress seems to have happened since 
autumn 2013. 
Still, only Luxembourg and The Netherlands have implemented the directive 
unreservedly, which is not surprising as both countries had it implemented before March 
2011! The Luxembourg Green might strike as “cheating”, but in the in-sourcing-prone 
public sectors, the LUX good common sense to refrain from building their own 
comprehensive healthcare services (which LUX certainly could have afforded), and let its 
citizens seek care in neighbouring countries, does deserve recognition. 
The subjective view from patient organisations (Graph below) agree well with the real 
life situation. Several national bodies did argue that the formal inclusion of the EU 
directive should be a basis for a Green score. As there are significant information gaps 
and other obstacles, this has not been accommodated. Austrian patients, in particular, 
seem unaware of the cross-border option. 
 
Figure 8.10.1.8 Survey responses to “Can patients in your country choose to be treated in 
another EU state OF THEIR OWN CHOICE, on the same economic terms as for treatment at 
home? Non-EU states get a Yellow “Not applicable” score by definition. The Green Bulgarian 
score from 2013 was deemed to lack credibility, which seems right.  
Following on the EU cross-border directive 2011, the real life implementation of the EU 
cross-border directive will probably take time. With The Netherlands as a notable 
exception, there seems to be an endemic problem in the form of control freaks (= Over-
anxious regulators?)  in healthcare administration slowing down the process. Penetration 
of the Dutch observation that “free access to cross-border care will not exceed 1% of 
healthcare budgets” seems to require assisted delivery. 
The graph above illustrates the results from the HCP Patient Organisation survey. 
Sources of data: Survey commissioned for Heart Index by HCP from Patient View 2014, 
http://ec.europa.eu/health/cross_border_care/consultations/cons_implementation_ern_e
n.htm#results , National healthcare agencies. 
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1.9 Provider catalogue with quality ranking 
In 2005, Dr. Foster of the UK was the single shining star on the firmament of provider 
(hospital) listing, where patients could actually see which hospitals had good results in 
term of actual success rates or survival percentages. Today, that has evolved into “NHS 
Choose and Book”13. 
In 2014, there are still only a few more examples, where the Health Consumer 
Powerhouse believes that the most notable is the Danish 
www.esundhed.dk/sundhedskvalitet/Pages/default.aspx , where hospitals are graded 
from  to  as if they were hotels, with service level indicators as well as actual 
results, including case fatality rates on certain diagnoses. Perhaps the most impressive 
part of this system is that it allows members of the public to click down to a link giving 
the direct-dial telephone number of clinic managers. 
In 2014, the Danish Sundhedskvalitet and the British NHS Choices remain the standard 
European qualifications for a green score. The “best clinics” published by the weeklies 
LePoint/Figaro in France gives a Green in 2014, as the HCP survey indicated a high 
degree of familiarity with that among patients. Also, in 2014 Estonia, The Netherlands, 
Norway, Portugal and Slovakia score Green. Germany, scoring Yellow in 2012, now 
scores Green (again) as public access to this information has been restored. Sweden has 
the information available in a 400+ page book, but that can hardly be described as 
easily accessed by patients. 
 
Figure 8.10.1.9  The Yellow scores for Iceland and Malta are awarded not to discriminate against 
islands having only one real hospital each. 
Sources of data: Survey commissioned for Heart Index by HCP from Patient View 2014, 
www.drfosterhealth.co.uk/; www.esundhed.dk/sundhedskvalitet/Pages/default.aspx; 
www.sykehusvalg.no/sidemaler/VisStatiskInformasjon____2109.aspx ; www.hiqa.ie/ ; 
http://212.80.128.9/gestion/ges161000com.html, www.bqs-institut.de/. Non-CUTS data. 
 
1.10 EPR penetration 
                                           
13 www.chooseandbook.nhs.uk  
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Percentage of GP practices using computer for storage of individual patient data and 
communication with other parts of the healthcare system. Finally in 2014, 20 years later 
than what should have been, this is becoming the norm in Europe! 
Sources of data: 
http://ec.europa.eu/public_opinion/flash/fl126_fr.pdf ;  
http://www.europartnersearch.net/ist/communities/indexmapconso.php?Se=11 ; 
www.icgp.ie ; Commonwealth Fund International Health Policy Survey of Primary Care 
Physicians"Benchmarking ICT use among GP:s in Europe"; European Commission, April 
2008; study made by Empirica, Bonn, Germany (p.60), Gartner Group. CUTS data. 
 
1.11 Do patients have access to on-line booking of appointments?  
The supply/demand ratio for specialist appointments or major surgery is very similar to 
that of hotel rooms or package holidays. There is no real reason why patients should not 
be able to book available “slots” at their convenience. This exists rather sparingly in 
Europe; in 2009, one of the only two Green scores went to Portugal, where “4 million 
people in the Lisbon region” were said to have access to this service. In 2014, thirteen 
countries have made this service available to sizeable groups of citizens – quite an 
improvement (2013: 9 countries)! As is illustrated by the Macedonian example, this 
service has the potential to more or less eradicate waiting lists from a healthcare 
system! 
 
Figure 8.10.1.11  The cut-offs to get a Yellow or Green have been unchanged since 2009. 
Sources of data: Survey commissioned by HCP from Patient View 2014. National 
healthcare agencies. 
 
1.12  e-Prescriptions  
HCP survey question: 
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“Can your country's patients collect drugs from a pharmacy with the prescription being 
sent electronically? [This is known as ‘e-prescriptions’, and no paper prescription is 
issued.]” 
1. Yes, this facility is widely available. 
2. It does exist, but is only offered by a few pioneering doctors/clinics/ hospitals. 
3. No (or it is very rare). 
 
Figure 8.10.1.12 Survey responses to the above question. 
Croatia and the Nordic countries are leading Europe.  
Sources of data: Survey commissioned by HCP from Patient View 2014. "The set-up of 
guidelines in support of European e-Prescription interoperability (2011-2013)", Empirica, 
Bonn); National healthcare agencies. 
 
 
8.10.2 Waiting time for treatment 
2.1 Family doctor same day access 
Testing a very reasonable demand: Can patients count on seeing a primary care doctor 
today, on the only indication “The patient suffers from the opinion that he needs to see 
a doctor”? 
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Figure 8.10.2.1a Survey responses to the question: “Can your country's patients see their primary 
care doctor that same day (with or without an appointment)?” 1.0 = all yes; 3.0 = all “normally 
not”. In Serbia, primary care centres are open for “drop-in” patients 24/7; the negative bias of 
patient responses is unexplained. 
The responses on this indicator basically show that there is no logical explanation for 
waiting times in primary care; the findings seem to be randomly placed in the order of 
national wealth;  there is no correlation with financial matters (GDP or healthcare spend 
per capita) nor the range of services provided, nor the density of primary care network 
(see graph below). In some rather unexpected countries, the GP even has the obligation 
to answer the phone to every patient registered in his practice 24 hours per day, 7 days 
a week. 
 
Figure 8.10.2.1b Doctors per 100 000 people (broad bars) and Number of outpatient contacts per 
person (narrow bars). As the graph shows, there is very poor correlation between doctors per 
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capita and Access to doctor. There are some culture streaks: the Nordic countries (green broad 
bars) only want patients to see a doctor when really sick. Swiss, Portuguese and Dutch do not 
disturb their doctors too much, either. The very low numbers of visits per doctor in Cyprus or 
Greece (which has by far the highest number of doctors per capita) could possibly be under-
reporting of visits for tax evasion reasons. 
Sources of data: Patients' Perspectives of Healthcare: Waiting times in Europe; survey 
commissioned by HCP 2014. WHO Health for All database, April 2014. National 
healthcare agencies; journal search. Non-CUTS data.  
 
2.2 Direct access to specialist 
Can patients see a specialist without first having to gain a referral from a primary-care 
doctor? 
This indicator happens to be the most disputed of all in the history of HCP indexes. 
However, the EHCI research does not take religious beliefs into consideration, be they 
moslem, catholic or the Faith in GP Gatekeeping. Consequently, it has been kept since 
2005, and seems to confirm the notion that “no significant effects of gatekeeping were 
found on the level of ambulatory care costs, or on the level or growth of total health 
care expenditure"14. 
Danish patients are particularly sanguine about being able to see a specialist directly; in 
Denmark, the GP or the A&E department are supposed to be the only points of entry to 
the healthcare system! 
 
Sources of data: Patients' Perspectives of Healthcare: Waiting times in Europe; survey 
commissioned by HCP 2014. National healthcare agencies with healthcare officials; 
www.im.dk/publikationer/healthcare_in_dk/healthcare.pdf ; www.ic.nhs.uk/ ; 
www.oecd.org, www.vantetider.se . Non-CUTS data. 
 
                                           
14
G Van Merode, A Paulus, P Groenewegen: Does general practitioner gatekeeping curb health 
care expenditure? J Health Serv Res Policy. 2000 Jan ;5 (1):22-6. See also Kroneman et al: Direct 
access in primary care and patient satisfaction: A European study. Health Policy 76 (2006) 72–79 
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2.3 Major non-acute operations <90 days 
What is the interval between diagnosis and treatment for a basket of coronary 
bypass/PTCA and hip/knee joint? It is difficult to avoid the observation that countries, 
which do have official waiting time statistics (Ireland, Sweden, UK etc), this is in itself a 
not very flattering circumstance. Countries such as Germany, where waiting times tend 
to vary in the 2 – 3 weeks range, have never felt the urge to produce waiting time data, 
for principally the same type of reason that Madrid has less snow-ploughs than Helsinki. 
 
Figure 8.10.2.3 Survey responses on major elective surgery waiting times. If the blue/maroon 
bars are higher that the green bars, that indicates waiting times having got longer during the 
“financial crisis years, and with a small improvement in 2014. 
As the graph shows, this is one of the few EHCI indicators, where traces of the financial 
crisis show up: waiting times for (expensive) elective surgery seemed increase slightly 
between 2009 and 2013, most notably in some countries severely hit by the crisis. 
However, this effect, if not an artefact, was quite modest, and 2014 seems to show 
improvement in many countries. 
Survey results for small countries should be taken with caution due to the limited 
number of survey responses! 
Sources of data: Patients' Perspectives of Healthcare Waiting times in Europe; survey 
commissioned by HCP 2014. National healthcare agencies. Non-CUTS data. 
 
2.4 Cancer therapies < 21 days 
This indicator measures the time to get radiation/chemotherapy after decision to treat 
(DTT). The time limit for a Green score is, and should be, much tighter for cancer 
treatment than for elective surgery. Encouragingly, the general level of accessibility to 
cancer care is superior to that of elective surgery also when the much tighter cut-off for 
a Green score (21 days vs. 90 days) is taken into consideration. 
The Patient Organisation survey commissioned by HCP had the same logic as for elective 
surgery (above) with an average response score of 1.0 for cancer treatment meaning 
essentially “everybody receives treatment within three weeks” to 3.0 meaning 
“everybody waits more than three weeks. In 2009, the average score was 1.692, in 
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2012, the average score was 1.789, 1.871 in 2013 and 1.833 in 2014. Interestingly this 
shows the same tendency as waiting times for elective surgery: an austerity-induced (?) 
slight increase of waiting time for these costly treatments between 2009 and 2013, and 
a minor improvement in 2014. 
Sources of data: Survey commissioned by HCP 2014. Cancer wait report from the 
Swedish Board of Health and Welfare (2014). National healthcare agencies. Non-CUTS 
data. 
 
2.5 CT scan < 7days 
As a representative for waiting times for advanced diagnostics was chosen Time to get a 
CT scan after referring doctor’s decision. There proved to be some difficulty making 
respondents (in national healthcare agencies) not answer in terms of “acute” or “non-
acute” examinations. Again, is has to be emphasized that waiting times for a CT scan is 
both poor service quality and also increases costs, not saving money, as the procedure 
of keeping track of patients for weeks/months is by no means costless, and the 
examination itself is if anything cheaper if the patient (and the care provider) has the 
underlying cause fresh in their minds. 
The Patient Organisation survey commissioned by HCP had the same logic as for elective 
surgery (above) with an average response score of 1.0 for a non-acute CT scan meaning 
essentially “everybody receives an examination within one week” to 3.0 meaning 
“everybody waits more than three weeks”. 
 
Figure 8.10.2.5 Survey responses non-acute CT scan waiting times. < 7 days for a Green might 
seem tight, but there is no real life reason to have longer waits. Albanian and Icelandic scores 
have been modified from national data. 
Sources of data: Survey commissioned by HCP 2014. National healthcare agencies. Non-
CUTS data. 
 
2.6 A&E department waiting time 
New indicator in 2013. HCP patient organisation survey question: 
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“Which of the following would be the more TYPICAL waiting time in your country for a 
visit to the Accident and Emergencies department of a hospital? [Please regard “waiting 
time” as the period between arrival at the hospital door and when a doctor starts 
treating/attending to your problem.] 
1. Typically LESS THAN 1 hour. 
2. Typically MORE THAN 1 hour, but LESS THAN 3 hours. 
3. Frequently MORE THAN 3 hours.” 
 
Figure 8.10.2.6 Survey responses on A&E department waiting times 
It is probably not a coincidence that for the two countries scoring lowest on Accessibility, 
Sweden and Ireland, this spills over into long A&E waiting times! The FYROM score has 
been adjusted based on official data. 
Sources of data: Survey commissioned by HCP 2013. National healthcare agencies. Non-
CUTS data. 
 
8.10.3 Outcomes 
The Outcomes sub-discipline assesses the performance of different national healthcare 
systems when it comes to results of treatment. The healthcare professionals sometimes 
tend to think about the healthcare systems predominantly in the terms of outcomes – 
saying that what really counts, is the result. We do agree to some extent, and this is 
reflected in the weight attributed to the outcomes sub-discipline indicators. 
 
3.1 Decrease of CVD Death Rates 
Data availability on the Acute Heart Infarct (AMI) in-hospital case fatality indicator is 
shockingly fragmented and incoherent over Europe. 
For this reason, that indicator has been replaced in the EHCI 2014 by the indicator 
“Inclination of the long-time trend line for ischaemic heart disease Standardized Death 
Rates”. This is based on the assumption that modern healthcare is the dominating 
reason for the decrease of cardiac deaths. That lifestyle changes are not the major 
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factor is supported by the discussion on the Diabetes Epidemic15. Diabetes shares most 
of the risk factors with CVD, and with the exception of smoking rates slowly decreasing, 
other risk factors such as obesity, drinking and sedentary lifestyle are on the increase. 
The actual indicator data is the steepness of the long time trend line inclination. This 
calculation has been done on the logarithmic values of the SDR numbers to compensate 
for the fact that e.g. France starts the comparison at an SDR around one 6th of some 
CEE countries (see graph below). 
 
 
Source of data: WHO Health for All database, April 2014. CUTS data. 
 
3.2 Decrease of stroke death rates 
Using the same logic as for CVD finally made it possible to introduce a long wanted 
indicator for the largest cause of death after CVD and cancers; stroke: 
                                           
15 Diabetes Atlas 6th edition; 2013 
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Source of data: WHO Health for All database, April 2014. CUTS data. 
 
3.3 Infant deaths 
Infant mortality rate is the number of infants dying before reaching one year of age, per 
1,000 live births in a given year. In the well developed countries the increased infant 
mortality occurs primarily among very low birth weight infants, many of whom are born 
prematurely; in Europe, very low birth weight infants probably account for more than 
half of all infant deaths. In Europe, with infant deaths normally counting below 6/1000, 
good check-ups during pregnancy and access to state-of-the-art delivery care are 
probably the key factors behind attaining really low numbers. Iceland has the lowest 
infant death rate on Earth, less than 2/1000. 
This indicator might be the best single indicator, which could be used to judge the 
overall quality of a healthcare system. It is interesting to note that this indicator seems 
totally resilient to effects of financial crises; infant mortality numbers have been, and still 
are, steadily improving since 2005! The Green/Yellow/Red cut-offs have been kept the 
same since the start of the EHCI. The number of countries scoring Green has increased 
from 9 in 2006, to 22 in 2014, (plus Scotland)! 
The country average keeps dropping, in spite of any “financial crisis”: from 4.49 in EHCI 
2012, to 4.22 in 2014, in spite of introducing two new countries with infant deaths close 
to 6. 
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Sources of data: WHO Europe Health for All mortality database April 2014, latest 
available statistics. Later data for some countries reported by national bodies. CUTS 
data. 
 
3.4 Ratio of cancer deaths to incidence 2012 
The  EHCI 2008 indicator on cancer outcomes was the more conventional 5-year survival 
rates of cancer (all types except skin). As no more recent data than EUROCARE-4, 
(patients diagnosed 1995 – 1999) data was available in the spring of 2012, the very 
comprehensive paper by J. Ferlay et al, listing cancer incidences and cancer deaths in 
2008 for all 34 countries was chosen as 2012 indicator data. In this indicator, a ratio of 
less than 0.4 for Deaths/Incidence, would in principle be equal to a survival rate > 60%. 
As there was a 16-month interval between the EHCI 2012 and EHCI 2013, fate arranged 
that Ferlay et al published a paper based on the same data for the year 2012 in time 
for this report. This means that the data in the graph below shows the situation in 2008 
and 2012, i.e. two years “straddling” the financial crisis. Unfortunately, this data is still in 
2014 the most recent comprehensive cancer mortality data. 
As this report has observed numerous times, it is very difficult to trace any effects of 
financial austerity on Outcomes of treatment of serious diseases! Cancer survival keeps 
improving, also in countries known to be hit particularly hard by austerity. 
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Sources of data: J. Ferlay et al., Annals of Oncology, 2010, J. Ferlay et al. European 
Journal of Cancer 49 (2013) 1374–1403. CUTS data. 
 
3.5 Preventable Years of Life Lost 
This indicator measures Years lost per 100.000 population 0-69, all causes of death. 
Potential Years of Life Lost (PYLL), used by the WHO and OECD, take into account the 
age at which deaths occurs by giving greater weight to deaths at younger age and lower 
weight to deaths at older age. 
Potential Years of Life Lost are calculated from the number of deaths multiplied by a 
standard life expectancy at the age at which death occurs. PYLL is preferred as an 
indicator for the EHCI over and above the popular “Healthcare Amenable Deaths”, as 
that indicator automatically gives low values to states with a low CVD death rate, such 
as the Mediterranean states, most obviously France. 
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Source of data: WHO Detailed Mortality Database, excerpt May 2014. CUTS data. 
 
3.6 MRSA infections 
This indicator measures the percentage of hospital-acquired strains being resistant. The 
aim of this indicator is to assess the prevalence and spread of major invasive bacteria 
with clinically and epidemiologically relevant antimicrobial resistance. As in the previous 
year’s indexes, The European Antimicrobial Resistance Surveillance System (ECDC EARS-
net) data is used. The data is collected by 800 public-health laboratories serving over 
1300 hospitals in 31 European countries. 
The share of hospital infections being resistant has been uncannily stable over time in 
many countries, which is slightly surprising: One would think that either a country has 
the problem fairly well under control (such as the Nordics and The Netherlands) or one 
would expect fluctuation over time. Why countries like Germany and France can have 
this rate stable at just over or under 20 % remains a mystery. 
The real improvement has been achieved in the British Isles: through a very dedicated 
effort, both Ireland and the U.K. have brought their resistance rates down from 40 – 45 
% in 2008 into the low 20’s (Ireland) and less than 15 % (UK). 
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Sources of data: ECDC EARS-net database, accessed October 8, 2014 (most data 2012). 
CUTS data. 
 
3.7 Abortion rates 
New indicator for EHCI 2013. 
The scoring of this indicator is somewhat complex. The scores are fundamentally based 
on the principle that free, legally defined abortion should be available for women in any 
country16. At the same time, using abortion as a contraceptive must be regarded as very 
undesirable. This is illustrated by Russia, where the abortion rate in the mid-1990’s was 
~160 abortions per 100 live births, and still today is in a league of its own at 95 per 100. 
Remnants of the same practice can be discerned in former Warsaw pact countries (see 
Graph below). 
There are four countries in Europe, where free abortion rights do not exist: Cyprus, 
Ireland, Malta and Poland. These countries have been given the unique new Purple 
score (= 0 points), even though new Irish legislation allows for abortion in extreme 
circumstances and subject to external verdict. It has been well known for centuries that 
stigmatizing or banning abortion results in tragedies such as the female dentist, who 
died in a Galway hospital because doctors did not dare/want to perform an abortion on 
her (already dying) foetus. Legal bans do not prevent abortions but rather turns them 
into a major health risk, forcing women to go abroad or having an abortion under 
obscure, insecure conditions. 
Austria does not ban abortion, but it is not provided by public hospitals, which results in 
defunct abortion statistics. 
                                           
16 European Parliament REPORT on Sexual and Reproductive Health and Rights, (2013/2040(INI)), 
Committee on Women’s Rights and Gender Equality, Rapporteur: Edite Estrela, 2013-09-26 
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Source: WHO Health for All database, April 2014. CUTS data. 
 
3.8 Depression 
Since 2005, HCP has wanted to introduce an indicator on quality of psychiatric care. Due 
to substantial methodological and definitions problems, resulting in gross inconsistencies 
of data, we rejected the usual indicators as psychiatric beds per population, mental 
disorders hospitalisation, drug sales and many others. The decline of suicide in a ten 
year period, e.g. since 1995, somehow returned, every year, to the expert panel's 
working sessions. But, adding to uncertain data reliability, there was a practical problem 
to solve: taking into account the very significant peak of suicide in Eastern European 
countries in 1991-1995, how to make the indicator fair for the whole European region? 
In 2008, following long and vivid discussions, the indicator “inclination of e-log line for 
suicide SDR:s 1995 – l.a.” was introduced, being fully aware of its interpretative 
limitations. 
In 2012, it became evident that general improvement in living conditions, particularly in 
CEE, and later the effects of the financial crisis in countries such as Greece outweighed 
the effects of psychiatric care on suicide rates. In the intense search for a relevant 
indicator on mental health, we finally elected to combine (arithmetic average) the 5 
questions in the table below from a Special Eurobarometer on Mental Health: 
How often during the past 4 weeks …? 
% "all the time" + % "most of the time" 
How often during the past 4 weeks …? 
% "never" + % "rarely" 
Have you felt happy 
Have you felt calm and 
peaceful 
Have you felt so down in 
the dumps that nothing 
could cheer you up 
Have you felt 
downhearted and 
depressed 
Have you felt 
particularly tense 
For Norway, not being included in the Eurobarometer, we found a national study directly 
comparing with the same Eurobarometer. 
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Sources: Special Eurobarometer 345, October 2010. ”Psykisk helse i Norge”, report 
2011:2, www.fhi.no , WHO World Database on Happiness, 2011, WHO Mental Health 
Atlas, 2012. Strongly non-CUTS. 
 
8.10.4 Range and reach of services provided 
4.1 Equity of healthcare systems 
The simple indicator “What % of total healthcare spend is public?” was introduced in 
2009 as a measure on equity of healthcare systems. Switzerland was judged to be a 
victim of the same kind of definition problems as pre-reform (2006) Netherlands, where 
on formal grounds a large part of the common health insurance was reported as private 
spend, and given a Green score.  
In some countries, the public share of healthcare financing has decreased slightly, most 
notably in Ireland. According to official data, Greece is not in that group, which is 
interesting. 
 
Sources of data: WHO HfA database, April 2014. CUTS data. 
 
4.2 Cataract operations per 100 000 age 65+ 
Surgical procedures by ICD-CM, Cataract surgery, Total procedures performed on 
patients of all ages, but divided by 100 000’s of population over 65. Few cataracts are 
performed on patients under 65, and age-separated data is not available. 
Cataract operations per 100 000 total population has been continuously used in previous 
EHCI editions as a proxy of the generosity of the healthcare systems to provide non-
lifesaving care aimed to improve the quality of life of the patient. Cataracts have been 
selected because they are relatively inexpensive and provide large improvement in 
patient Quality of Life, thus being fairly independent on GDP/capita of a country. Since 
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2008, the indicator has been age-adjusted following a suggestion made by Irish officials 
(which is not surprising, as the non-age standardized indicator would have 
disadvantaged Europe’s youngest nations; Macedonia, Ireland and Romania). 
 
This indicator did prove unexpectedly complicated. Some data faithfully reported to and 
quoted by the OECD turned out to be totally off the mark: the OECD Health Data 
number for Belgium used to be 204 868 cataract operations/year. Considering that an 
annual cohort of Belgians 65+ is not much greater than 100 000, that number would 
mean that eventually every single elderly Belgian would have cataract ops on both eyes! 
The Belgian Ministry of Health agreed about the absurdity of the number, and rapidly 
reported what they considered the accurate number: 107 056 operations, a number the 
research team could believe! This awkward procedure puts the searchlight on the fact 
that very strange data can be accepted in official sets of data, as it looks without further 
consideration. 
Belgian data has lately been corrected also in international databases. 
Sources of data: OECD Health Data 2012, WHO HfA database April 2014, WHO 
Prevention of Blindness and Visual Impairment Programme, European Community Health 
Indicators, National healthcare agencies. Non-CUTS data. 
 
4.3 Kidney transplants per million population 
This indicator measures procedures per million population. There is a commonly 
encountered notion that this number is greatly influenced by factors outside the control 
of healthcare systems, such as the number of traffic victims in a country. It must be 
judged that the primary explanation factors are inside healthcare, such as “the role and 
place of organ donation in anaesthesiologists’ training”, “the number of Intensive Care 
Unit beds p.m.p.”, the organisation of healthcare to optimise the handling of organs, etc. 
Experience tells that well-implemented national strategies can significantly increase 
donations. 
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Sources of data: Council of Europe Newsletter INTERNATIONAL FIGURES ON 
DONATION AND TRANSPLANTATION 19 (2014), Ministries of Health direct 
communication. CUTS data. 
 
4.4 Is dental care included in the public healthcare offering? 
In past years, the very simple indicator “What percentage of public healthcare spend is 
made up by dental care?” was selected as a measure of affordability of dental care, on 
the logic that if dental care accounts for close to 10 % of total public healthcare 
expenditure, this must mean that dental care is essentially a part of a fair public 
healthcare offering. 
2014, data on this indicator comes mainly from the OECD Health at a Glance 2014: 
“Unmet needs for dental examination”. Albania, FYROM and Serbia retain their EHCI 
2013 scores.  
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Sources of data: OECD Health at a Glance 2014, Eurostat: 
http://appsso.eurostat.ec.europa.eu/ . European Observatory HiT reports. National 
healthcare agencies.  CUTS data. 
 
4.5 Informal payments to doctors 
Mean response to question: "Would patients be expected to make unofficial payments?" 
with range of answers: plain “No!”, “Sometimes, depends on situation” and “Yes, 
frequently”. The indicator was first introduced in 2008. As an informal payment was 
considered any payment made by the patient in addition to official co-payment. That 
survey on informal payments was the first cross-European survey done ever on this 
problem, and was repeated in 2009 and 2012 - 2013, with highly compatible results 
compared with 2008. 
In 2014, the countries fall in three distinctive groups, making the R/Y/G scoring natural. 
These results have also been remarkably stable over the years, e.g. with Portugal and 
Spain scoring Green, and France and Austria scoring Yellow. 
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Sources of data: Survey commissioned from Patient View by HCP 2014. National 
healthcare agencies. Non-CUTS data. 
 
4.6 Long term care for the elderly 
This indicator looks into what is often referred to as a historic challenge for Europe: how 
to care for the rapidly aging population? The result reflects not only today’s investment 
in care, and accordingly, the future needs for coping with the growing demand. It also  
shows the imbalance between public caring and unofficial contributions. It can be 
assumed that in all countries elderly people are given some kind of attention; should the 
family and informal networks take the burden or can they trust public systems to assist? 
This is a notoriously difficult indicator, not least as long term elderly care is reported 
under social services rather than under healthcare in many countries. 
The HCP team made considerable effort to find more outcomes-related data. Since 
2012, we have had to settle for “# of nursing home and elderly care beds per 100 000 
population 65+”.  
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In 2013, this was corroborated against the parameter “% of GDP spent on Long Time 
Care”, divided by “% of population ≥ 75 years of age” (see graph below). 
The beauty of the “% of GDP / % of population 75+” parameter is that is it self-
calibrating, i.e. there is no need for calculating Purchasing Power Parity or other radio 
noise-enhancing operations. As institutional care is costly, it came as no surprise that 
the two parameters show noticeable correlation. 
 
Source: WHO Health for All database, April 2014. Eurostat, Eurohealth 17 No. 2-3 
(2011), OECD Health at a Glance 2014. CUTS data. 
 
4.7 Share of dialysis done outside of clinics 
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Dialysis is necessary for the survival of patients with renal and liver malfunctions. There 
are a few ways to perform this treatment. Dialysis performed as clinic-bound dialysis 
(hemo-dialysis: HD) has several drawbacks: 
a) Treatment episodes are usually 3x4 hours per week, which is a far cry from the 
168 hours per week of functioning healthy kidneys. Patients who do home 
dialysis (Peritoneal dialysis; PD, or HD in the home) frequently treat themselves 
up to 7 x 6 hours, i.e. nightly, with better treatment outcomes. 
b) Patients have great difficulties keeping a job, as dialysis requires presence in a 
clinic essentially three days a week. 
c) Dialysis in a clinic is much more expensive, typically kEUR 50 – 60 per patient 
per year. 
It seems that a low rate of home dialysis is not mainly due to preferences/capabilities of 
patients, but rather due to either 
i. Lack of professionalism of local nephrologists (there are centres of excellence 
around which close to 50% of dialysis patients dialyse themselves in the home), 
or 
ii. Greed (clinic dialysis is very profitable for the clinics). 
For these reasons, a high share of home dialysis gives a Green score on this indicator. 
 
Sources: European Renal Association-EDTA Annual Report 2012. www.ceapir.org. 
National Ministries. Basically CUTS data. 
 
4.8 % of births by Caesarean section 
New indicator for the EHCI 2012. In scoring, it has been assumed that high Caesarean 
rates are an indication on poor pre-natal support and poor baby delivery services – 
consequently, a high Caesarean rate has been given a Red score. The general 
recommendation is that a woman should not have more than two Caesarean deliveries, 
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which strongly indicates that complete recovery cannot be expected. Also, the typical 
French practice for getting back in shape after a delivery – post-natal physiotherapy – 
seems both more humane and more economical than invasive surgery. 
This way of delivery can be medically important and should of course be available. But 
HCP suspects that Caesarean section may camouflage a lack of good information and 
support before delivery as well as lack of access to pain control. 
The highest rates of Caesareans in the world are found in Cyprus, Greece and Latin 
America (Brazil and Venezuela also close to 50 %). 
Please note in the graph below that even though a Caesarean is costly, there is 
definitely no correlation between national wealth and high Caesarean rates! 
Source: WHO Health for All database, April 2014. CUTS data. 
 
 
 
8.10.5 Prevention 
5.1 Infant 8-disease vaccination 
Percentage of children vaccinated (Diphtheria, tetanus, pertussis, measles, poliomyelitis, 
rubella, hepatitis B and haemophilus influenza B, arithmetic mean). 
Vaccination is generally regarded as cost-effective prevention, which is reflected by 
several less wealthy countries scoring Green. 
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Sources of data: WHO HfA database, April 2014. National vaccination registries. National 
healthcare agencies. CUTS data. 
 
5.2 Blood pressure 
This indicator measures the % of adult population registering high blood pressure (> 
140/90). 
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As is evident from the graph, hypertension in Europe is not associated with high 
standard of living, but rather a combination of lifestyle factors (CEE food, smoking and 
drinking habits) and a lack of treatment tradition – hypertension treatment is not 
expensive. 
Source: WHO World Health Statistics 2014. CUTS data. 
 
5.3 Smoking prevention 
The Tobacco Control Scale (TCS) has been used as a measure of countries’ efforts on 
smoking prevention. It is made up by six indicators: Price (30), Public place bans (22), 
Public information campaign spending (15), Advertising bans (13), Health warnings (10) 
and Treatment (10). Numbers in parentheses denote the weight (contribution of a Full 
score to the TCS maximum total of 100). 
Red/Yellow/Green scores have been taken from the Source publication, with the 
exception of the Green score for Sweden – a Red score to the country having the lowest 
smoking prevalence in Europe would be ludicrous!  
 
Source: Joossens, L. & Raw, M.: Tobacco Control Scale 2013 in Europe. 
 
5.4 Alcohol consumption 
Unlike cigarette smoking, alcohol as a risk factor is not always harmful. It has been 
shown in numerous studies that a modest alcohol intake (the equivalent of one glass of 
wine per day for women, and 1 – 2 glasses per day for men) reduces the risk of death 
from CVD enough to result in a lower mortality than for total abstainers. 
On the other hand, drinking vast quantities of alcohol on single occasions (“binge 
drinking”) is a known risk factor for CVD, and also for some cancer forms. This seems 
particularly true for binge drinking involving hard liquor consumption. 
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For these reasons, this indicator is based on “hard liquor consumption (litres of pure 
alcohol), binge drinking adjusted”. The adjustment is made by multiplying the nominal 
consumption by 1 + [percentage of population having had ≥ 5 drinks on their latest 
drinking occasion]. According to NHS Health Scotland, “Scotland has 70% more alcohol-
related deaths than England”, why Scotland receives a Red score. 
Note the low alcohol consumption of the three countries having the highest share of 
moslem population! 
 
Sources: WHO HfA April 2014, Special Eurobarometer 331 April 2010 (for binge drinking 
habits). National reports. Mainly CUTS data. 
 
5.5 Physical activity 
Physical exercise is beneficial to reduce risk for illness for a vast spectrum of diseases. 
There is statistics on parameters such as “number of hours of jogging or similar per 
person per week” for many countries. However, the radio noise level of this data is 
probably quite high. Also, this is a parameter which is very difficult for any decision 
makers to change for a significant part of a population within a reasonable time frame. 
Therefore, the physical exercise parameter chosen for the EHCI 2014 is “number of 
hours of physical exercise in compulsory school” (counting a maximum of 10 school 
years). This is a parameter that e.g. a government has the power to change. 
England gets a Yellow score for not having a set national level for number of hours. 
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Source: www.eurydice.org; Recommended Annual Instruction Time in Full-time 
Compulsory Education In Europe 2013/14. National Scottish and Swiss data. CUTS data. 
 
 
5.6 HPV vaccination 
In recent years, many countries have included HPV vaccination for girls in their lower 
teens in national vaccination programmes. This indicator has been scored as: 
Green: National programme for HPV vaccination in place, free of charge to patient. 
Yellow: National programme for HPV vaccination, patient pays (significant part of) 
cost. 
Red: No national HPV vaccination programme.    
It would have been desirable to measure the degree of coverage of these vaccination 
programmes – such data is not yet available. 
Sources: European Centre for Disease Prevention and Control. Introduction of HPV 
vaccines in EU countries – an update. Stockholm: ECDC; 2012. Seme et al.: Acta 
Dermatovenerologica APA 2013; 22:21-25. 
www.bag.admin.ch/themen/medizin/00682/00684/03853/. National healthcare agencies. 
Mainly CUTS data. 
 
5.7 Traffic deaths 
This is a new prevention indicator introduced in 2014. It is not really healthcare 
dependent, but nevertheless amenable to decision making by humans. Traffic deaths, 
and also personal injuries due to traffic accidents, have been much reduced over the last 
30 – 40 years in almost all countries in Europe. There still are large variations between 
European countries, as is shown by the Graph below. The graph should also eliminate 
any speculation that the high organ transplant rates of Spain is due to a high number of 
traffic victims! 
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Source: WHO Health for All database, April 2014. 
          
8.10.6 Pharmaceuticals 
For reasons of copyright, HCP is not in a position to include graphs showing the actual 
data behind the drug use indicators, only relative comparisons. 
 
6.1 Rx subsidy % 
What percentage of total drug sales (including OTC drugs) is paid by public subsidy? 
Sources of data: WHO HfA database April 2014, EFPIA: The pharmaceutical industry in 
figures - Key Data 2013. EFPIA: Personal Communication. National healthcare and 
medical products agencies. 
Non-CUTS data. 
 
6.2 Layman-adapted pharmacopoeia 
Is there a layman-adapted pharmacopoeia readily accessible by the public (www or 
widely available)? The existence of these (a comprehensive data collection on all drugs 
registered and offered for sale in a country, searchable both on chemical substance and 
brand name, and containing at least the same information as do the packing leaflets, 
written in a way to be understandable by non-professionals) has grown considerably 
from 2005, when essentially only Denmark and Sweden had them. 
Today, 26 of the 36 countries plus Scotland in Europe have Internet pharmacopoeias. 
 
For all these countries, the information is traceable to the package leaflet texts provided 
by the drug manufacturers. France and Germany (not counted among the 26 above) 
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deviate – the information in their respective websites is every bit as comprehensive as in 
most countries, but it is very difficult to see who is the sender of the information. Spain 
seems to be a real hard-core country when it comes to allowing pharma companies to 
inform about prescription drugs direct to the public. This is probably not a big obstacle 
for Spanish members of the public – due to the high share of Hispanics among 
Americans, prescription drug information is readily available in Spanish on U.S. pharma 
company websites. 
Sources of data: HCP research 2010 – 2014. National healthcare agencies. Non-CUTS 
data. 
 
6.3 Novel cancer drugs deployment rate 
This indicator measures the use, in MUSD p.m.p., of the ATC code group L01XC 
(monoclonal antibodies). The measure DDD (Defined Daily Doses) rather than monetary 
value would have been preferable, but unfortunately the volume data contained 
inconsistencies. 
Sources of data: The IMS Health MIDAS database. CUTS data. 
 
6.4 Access to new drugs (time to subsidy) 
The indicator measures the time lag between registration of a drug, and the drug being 
included in the national subsidy system. 
This is one indicator, where the financial crisis effects show very clearly. Even in affluent 
countries such as Sweden or Switzerland, there has been a significant increase in the 
time lag between registration of a drug, and admission of the drug into national 
Pharmacy Benefits Systems (drug subsidy system). 
Sources of data: PATIENTS W.A.I.T. INDICATOR 2012 Report – based on EFPIA’s 
database (first EU marketing authorisation in the period 2009 – 2011). EFPIA: The 
pharmaceutical industry in figures - Key Data 2013. EFPIA: Personal Communication 
National Ministries of Health. Non-CUTS data. 
 
6.5 Deployment of arthritis medication 
The arrival of TNF-α inhibitor drugs (ATC code L04AB) meant a dramatic improvement 
for arthritis patients. Some countries are still restrictive on the use of these drugs, and 
as the graph below shows, this is not tightly correlated with GDP/capita. Drug volumes 
are expressed as Standard Units (an IMS Health measure, close but not identical to 
DDD:s) per 1000 prevalent population  ≥15 years. (DDD = Daily Defined Dose.)  
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Sources of data: IMS MIDAS database. For prevalence data: eumusc.net: Report v5.0 
Musculoskeletal Health in Europe (2012). Special Eurobarometer 272 (2007). National 
agencies. CUTS data. 
 
6.6 Metformin use 
Metformin is generally agreed to be the first-line medication for diabetics. It is also off-
patent, and therefore quite inexpensive. Therefore, it should be expected to find that all 
countries would have a similar level of metformin deployment per diabetic. AS can be 
seen from the graph below, in real life there is a four-fold difference in the prevalence 
adjusted per capita use of metformin. 
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It should be noted that the relative difference of national diabetes prevalence is only 
±15% from the European average, which makes it unlikely that the difference in 
metformin use is due to errors in the prevalence numbers.  
In the work on the HCP Euro Diabetes Index 201417 it was observed that countries who 
use a lot of metformin and insulin (Sweden, the UK, The Netherlands et al) were 
frequently very restrictive with innovative modern diabetes drugs such as gliptins! 
Sources of data: The IMS Health MIDAS database, IDF Diabetes Atlas 6th edition. 
National agencies. Mainly CUTS data. 
 
6.7 Antibiotics consumption 
As the following graphs will show, there is shocking disagreement between different 
sources regarding antibiotics consumption. The 2014 indicator is based on “Antibiotic 
use in eastern Europe: a cross-national database study in coordination with the WHO 
Regional Office for Europe”18 (3rd Graph below). That was used as a CUTS. 
The fact that this WHO report (based on wholesaler reports) disagrees violently with 
both the Eurobarometer on beliefs about antibiotics helping against viruses (2012), and 
with IMS Health pharmacy sales data (2013) makes the HCP team inclined to regard the 
WHO report as not trustworthy. A 2015 EHCI will revert to the 2013 methodology. 
In 2012, the indicator used was “% of population who know antibiotics are not effective 
against cold and flu”. EHCI 2013 uses actual per capita sales of antibiotics, with the 
assumption that a restrictive use is good from a resistivity point of view. 
 
 The EHCI 2012 indicator. 
Source: Special Eurobarometer 338, April 2010. CUTS data. 
                                           
17 http://www.healthpowerhouse.com/files/EDI-2014/EDI-2014-report.pdf  
18 The Lancet Infectious Diseases, 2014-03-20 
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The EHCI 2013 indicator. 
If the French, Brits and Belgians really do know that antibiotics do not work against viral 
infections: How come they use so much? 
The graph below illustrates the data of the 2014 WHO report. It probably has large 
errors! 
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The EHCI 2014 indicator. 
Source: “Antibiotic use in eastern Europe: a cross-national database study in 
coordination with the WHO Regional Office for Europe”, Lancet, 2014. CUTS data. 
 
8.11 External expert reference panel 
As is the standard working mode for all HCP Indexes, an external Expert Reference 
Panel was recruited. The panel met for two 6-hour sittings during the course of the 
project, the Panel Members having been sent the Index working material in advance. 
The following persons have taken part in the Expert Reference Panel work for EHCI 
2014: 
Name 
 
Affiliation 
Ulrik Bak Dragsted, MD, PhD Head of Infectious Diseases Unit, Roskilde Hospital, 
Denmark & President, The Danish Society of 
Internal Medicine 
Filippos Filippidis, Dr. School of Public Health, Imperial College, London 
Ian Graham, Professor Dr. Trinity College, Dublin 
Ulrich Keil, Professor Em. Dr. Dr. Institut für Epidemiologie und Sozialmedizin, 
Medizinische Fakultät der Westfälischen Wilhelms 
Universität Münster, Germany 
Lennart Welin, Associate Professor Dr. Lidköping Hospital, Sweden 
 
The Expert Reference Panel for a HCP Index has two core tasks: 
A. To assist in the design and selection of sub-disciplines and indicators. This is 
obviously of vital importance for an Index, if the ambition is to be able to say 
that a state scoring well can truly be considered to have good, consumer-friendly 
healthcare services. 
B. To review the final results of research undertaken by HCP researchers before the 
final scores are set. If the information obtained seems to clash too violently with 
the many decades of healthcare experience represented by the panel members, 
this has been taken as a strong signal to do an extra review of the results. 
The HCP wishes to extend its sincere thanks to the members of the panel for their 
fundamentally important contribution to the Index work, and for very valuable 
discussions. 
 
9. References 
9.1  Main sources 
The main sources of input for the various indicators are given in Table 8.7 above. For all 
indicators, this information has been supplemented by interviews and discussions with 
healthcare officials in both the public and private sectors. 
The “Single Indicator Score Sheets” are published on the Internet, so that all can see 
what main data have been used, and also the scoring methodology. These sheets are on 
www.healthpowerhouse.com/ehci2014-indicators/  . 
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Indicators, for which data could not be converted to straightforward numbers are 
missing on that site. Also, for copyright reasons, so is numerical data for indicators 
based on drug sales numbers, which are illustrated in a Powerpoint presentation on the 
website. 
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Appendix 1. The True Saga About Werner’s Hip Joint, or What Waiting 
Times Should Be In Any Healthcare System 
This is a true story, which happened in July 2013 in a small town of 8000 (winter) inhabitants in 
Languedoc, 50 km south of Montpellier. Werner, (not his real name) is a German military man 
who has retired with his wife to the south of France. The services described below were paid for 
by Werner’s normal German health insurance with no private top-up. Here goes: 
Like most expats in the little town, Werner was sitting on a Tuesday afternoon outside the Marine 
Bar taking a refreshment. Werner tells his wife: 
˗ Helga, dear, I believe I should have somebody look at my left leg. I have been having 
these pains for a year and a half now. 
˗ Werner, dear, that door across the street has a brass plate on it. It looks just like a 
doctor’s surgery! 
Werner limps across the street and finds that the brass plate adorns the door of the surgery of 
Dr. B, a local GP. Werner rings the bell, and explains his problem to the nurse/secretary opening. 
˗ Could Dr. B possibly have a look at my problem? 
˗ Not right now, but please come back in half an hour! 
Werner limps back across the street, finishes his beer, and goes to see Dr. B. Dr. B examines 
Werner and says: 
˗ I am afraid that this looks as if you might need a new hip joint. We will have to take a 
closer look. Are you doing anything special tomorrow? 
˗ No, I am retired, so I am very flexible. 
Dr. B picks up his phone, speaks for a couple of minutes, puts the receiver down and says to 
Werner: 
˗ You are booked for a CT scan tomorrow morning at 10:00 in Agde Radiology Centre (7 
km away). After that, come and see me again on Thursday at 3 pm! We should have the 
results by then. 
Werner goes and has the CT scan and reappears at Dr. B:s on the Thursday. Dr. B says: 
˗ I am afraid it seems that my first diagnosis was correct. You need your hip joint 
replaced. Are you doing anything special next week? 
˗ No, I am retired, so I am very flexible. 
Dr. B picks up the phone again, speaks for a few minutes and turns back to Werner. 
˗ You are expected in the Orthopaedic Clinic of the University Hospital of Montpellier19 at 
09:00 on Monday. Bring a small overnight bag with your necessities for a four-day stay! 
On the following Friday, Werner is discharged from the hospital, spick and span with a new hip 
joint. Calendar time for the entire sequence of events: 10 days! 
The important morale of the story: The big part of healthcare costs is always man-hours put in 
by healthcare staff. The 10-day procedure above has precious little room for man--hours at all. 
That is why it is cheaper to operate a healthcare system without waiting lists, than to have 
waiting lists! 
                                           
19 The oldest medical faculty in Europe. The 6th best hospital in France, according to a recent ranking. 
